CA3043748A1 - Sanitizer composition with probiotic/prebiotic active ingredient - Google Patents
Sanitizer composition with probiotic/prebiotic active ingredient Download PDFInfo
- Publication number
- CA3043748A1 CA3043748A1 CA3043748A CA3043748A CA3043748A1 CA 3043748 A1 CA3043748 A1 CA 3043748A1 CA 3043748 A CA3043748 A CA 3043748A CA 3043748 A CA3043748 A CA 3043748A CA 3043748 A1 CA3043748 A1 CA 3043748A1
- Authority
- CA
- Canada
- Prior art keywords
- sanitizing composition
- sanitizing
- composition
- active ingredient
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 365
- 239000004480 active ingredient Substances 0.000 title claims abstract description 86
- 239000006041 probiotic Substances 0.000 title claims abstract description 86
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 86
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 75
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 35
- 238000011012 sanitization Methods 0.000 claims abstract description 293
- 230000000694 effects Effects 0.000 claims abstract description 105
- 238000004519 manufacturing process Methods 0.000 claims abstract description 55
- 241000894006 Bacteria Species 0.000 claims abstract description 34
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims abstract description 23
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 100
- 239000004615 ingredient Substances 0.000 claims description 69
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 150000002148 esters Chemical class 0.000 claims description 27
- 244000052769 pathogen Species 0.000 claims description 27
- 229940097496 nasal spray Drugs 0.000 claims description 26
- 239000007922 nasal spray Substances 0.000 claims description 26
- -1 polyethylene Polymers 0.000 claims description 24
- 239000000654 additive Substances 0.000 claims description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 229920001223 polyethylene glycol Polymers 0.000 claims description 21
- 239000003906 humectant Substances 0.000 claims description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 16
- 230000000996 additive effect Effects 0.000 claims description 16
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 14
- 150000001298 alcohols Chemical class 0.000 claims description 14
- 230000001717 pathogenic effect Effects 0.000 claims description 14
- 230000000770 proinflammatory effect Effects 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000004599 antimicrobial Substances 0.000 claims description 10
- 230000007423 decrease Effects 0.000 claims description 10
- 102000000905 Cadherin Human genes 0.000 claims description 9
- 108050007957 Cadherin Proteins 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 230000000699 topical effect Effects 0.000 claims description 9
- 102000000541 Defensins Human genes 0.000 claims description 8
- 108010002069 Defensins Proteins 0.000 claims description 8
- 239000003205 fragrance Substances 0.000 claims description 8
- 230000003020 moisturizing effect Effects 0.000 claims description 8
- 102000015696 Interleukins Human genes 0.000 claims description 7
- 108010063738 Interleukins Proteins 0.000 claims description 7
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 7
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 6
- 230000000845 anti-microbial effect Effects 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 206010040880 Skin irritation Diseases 0.000 claims description 5
- 229940031569 diisopropyl sebacate Drugs 0.000 claims description 5
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004088 foaming agent Substances 0.000 claims description 4
- 229940080812 glyceryl caprate Drugs 0.000 claims description 4
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 4
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 4
- 230000036556 skin irritation Effects 0.000 claims description 4
- 231100000475 skin irritation Toxicity 0.000 claims description 4
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 claims description 3
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 3
- 241000588986 Alcaligenes Species 0.000 claims description 3
- 241000186000 Bifidobacterium Species 0.000 claims description 3
- 241001112696 Clostridia Species 0.000 claims description 3
- 241000186216 Corynebacterium Species 0.000 claims description 3
- 241000194033 Enterococcus Species 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 3
- 241000194036 Lactococcus Species 0.000 claims description 3
- DYIOQMKBBPSAFY-BENRWUELSA-N Palmityl myristoleate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCC DYIOQMKBBPSAFY-BENRWUELSA-N 0.000 claims description 3
- 241000235070 Saccharomyces Species 0.000 claims description 3
- 229940093532 cetyl myristoleate Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 claims description 3
- QVTWBMUAJHVAIJ-UHFFFAOYSA-N hexane-1,4-diol Chemical compound CCC(O)CCCO QVTWBMUAJHVAIJ-UHFFFAOYSA-N 0.000 claims description 3
- 229940051250 hexylene glycol Drugs 0.000 claims description 3
- 229940100573 methylpropanediol Drugs 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- DYIOQMKBBPSAFY-UHFFFAOYSA-N palmityl myristoleate Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCC=CCCCC DYIOQMKBBPSAFY-UHFFFAOYSA-N 0.000 claims description 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 3
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 2
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 2
- 241000186429 Propionibacterium Species 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 19
- 210000003491 skin Anatomy 0.000 description 82
- 244000005700 microbiome Species 0.000 description 21
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- 239000002562 thickening agent Substances 0.000 description 20
- 239000006260 foam Substances 0.000 description 17
- 239000002202 Polyethylene glycol Substances 0.000 description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 16
- 229920001296 polysiloxane Polymers 0.000 description 16
- 101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229940008099 dimethicone Drugs 0.000 description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 description 15
- 102000004890 Interleukin-8 Human genes 0.000 description 14
- 108090001007 Interleukin-8 Proteins 0.000 description 14
- 102000049262 human DEFB4A Human genes 0.000 description 14
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 14
- 229940096397 interleukin-8 Drugs 0.000 description 14
- 229920001451 polypropylene glycol Polymers 0.000 description 14
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 13
- 210000002510 keratinocyte Anatomy 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 241000736262 Microbiota Species 0.000 description 9
- 239000003623 enhancer Substances 0.000 description 9
- 239000002085 irritant Substances 0.000 description 9
- 230000003472 neutralizing effect Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000001052 transient effect Effects 0.000 description 9
- 150000001735 carboxylic acids Chemical class 0.000 description 8
- 230000008021 deposition Effects 0.000 description 8
- 102000007236 involucrin Human genes 0.000 description 8
- 108010033564 involucrin Proteins 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 102100037709 Desmocollin-3 Human genes 0.000 description 7
- 101710157874 Desmocollin-3 Proteins 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 6
- 229940047122 interleukins Drugs 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- BUOSLGZEBFSUDD-BGPZCGNYSA-N bis[(1s,3s,4r,5r)-4-methoxycarbonyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2,4-diphenylcyclobutane-1,3-dicarboxylate Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1C(C=2C=CC=CC=2)C(C(=O)O[C@@H]2[C@@H]([C@H]3CC[C@H](N3C)C2)C(=O)OC)C1C1=CC=CC=C1 BUOSLGZEBFSUDD-BGPZCGNYSA-N 0.000 description 5
- 229940117583 cocamine Drugs 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000002334 glycols Chemical class 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 4
- 150000002009 diols Chemical class 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000015788 innate immune response Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 229940094332 peg-8 dimethicone Drugs 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000193749 Bacillus coagulans Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 229940054340 bacillus coagulans Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000021995 interleukin-8 production Effects 0.000 description 3
- 231100000021 irritant Toxicity 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- NXQMCAOPTPLPRL-UHFFFAOYSA-N 2-(2-benzoyloxyethoxy)ethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCOCCOC(=O)C1=CC=CC=C1 NXQMCAOPTPLPRL-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010016936 Folliculitis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- JKRZOJADNVOXPM-UHFFFAOYSA-N Oxalic acid dibutyl ester Chemical compound CCCCOC(=O)C(=O)OCCCC JKRZOJADNVOXPM-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 229920002413 Polyhexanide Polymers 0.000 description 2
- 229920000289 Polyquaternium Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- BHGAOGZUKUXCDC-UHFFFAOYSA-N bis(14-methylpentadecyl) hexanedioate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCCCCCC(C)C BHGAOGZUKUXCDC-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 108060001132 cathelicidin Proteins 0.000 description 2
- POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 2
- 102000014509 cathelicidin Human genes 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 229940073499 decyl glucoside Drugs 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- HSEMFIZWXHQJAE-UHFFFAOYSA-N hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(N)=O HSEMFIZWXHQJAE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- FWWQKRXKHIRPJY-UHFFFAOYSA-N octadecyl aldehyde Natural products CCCCCCCCCCCCCCCCCC=O FWWQKRXKHIRPJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940105131 stearamine Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FTSXVYQZLNPTCM-UHFFFAOYSA-N (3-benzoyloxy-2,2,4-trimethylpentyl) benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(C)(C)C(C(C)C)OC(=O)C1=CC=CC=C1 FTSXVYQZLNPTCM-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- ALVZNPYWJMLXKV-UHFFFAOYSA-N 1,9-Nonanediol Chemical compound OCCCCCCCCCO ALVZNPYWJMLXKV-UHFFFAOYSA-N 0.000 description 1
- USZDQUQLJBLEDN-UHFFFAOYSA-N 1-(1-tetradecoxypropan-2-yloxy)propan-2-yl propanoate Chemical compound CCCCCCCCCCCCCCOCC(C)OCC(C)OC(=O)CC USZDQUQLJBLEDN-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- CKLFCQSAMZMOJN-UHFFFAOYSA-N 1-o,2-o-bis(2-octyldodecyl) 3-o-(3,3,4,4,5,5,6,6,7,7,7-undecafluoroheptyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CC(O)(CC(=O)OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(=O)OCC(CCCCCCCC)CCCCCCCCCC CKLFCQSAMZMOJN-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-BGYRXZFFSA-N 1-o-[(2r)-2-ethylhexyl] 2-o-[(2s)-2-ethylhexyl] benzene-1,2-dicarboxylate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=CC=C1C(=O)OC[C@H](CC)CCCC BJQHLKABXJIVAM-BGYRXZFFSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- YUSLYKMVQSVFDX-UHFFFAOYSA-N 2,2,3,3,4-pentahydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)C(O)(O)C(O)(O)C(O)=O YUSLYKMVQSVFDX-UHFFFAOYSA-N 0.000 description 1
- OMVSWZDEEGIJJI-UHFFFAOYSA-N 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Chemical compound CC(C)C(=O)OC(C(C)C)C(C)(C)COC(=O)C(C)C OMVSWZDEEGIJJI-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- HPKFFZSXDWPVLX-UHFFFAOYSA-N 2-[(2-pyridin-1-ium-1-ylacetyl)amino]ethyl dodecanoate;chloride Chemical compound [Cl-].CCCCCCCCCCCC(=O)OCCNC(=O)C[N+]1=CC=CC=C1 HPKFFZSXDWPVLX-UHFFFAOYSA-N 0.000 description 1
- CUEJHYHGUMAGBP-UHFFFAOYSA-N 2-[2-(1h-indol-5-yl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC=C1C1=CC=C(NC=C2)C2=C1 CUEJHYHGUMAGBP-UHFFFAOYSA-N 0.000 description 1
- AHSGHEXYEABOKT-UHFFFAOYSA-N 2-[2-(2-benzoyloxyethoxy)ethoxy]ethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCOCCOCCOC(=O)C1=CC=CC=C1 AHSGHEXYEABOKT-UHFFFAOYSA-N 0.000 description 1
- YEOWONAMJWJGQU-UHFFFAOYSA-N 2-[2-(2-ethylheptanoyloxy)ethoxy]ethyl 2-ethylheptanoate Chemical compound CCCCCC(CC)C(=O)OCCOCCOC(=O)C(CC)CCCCC YEOWONAMJWJGQU-UHFFFAOYSA-N 0.000 description 1
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- AWOTXJMTZAPRFT-UHFFFAOYSA-N 2-octyldodecyl n-[[1,3,3-trimethyl-5-(2-octyldodecoxycarbonylamino)cyclohexyl]methyl]carbamate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)NCC1(C)CC(NC(=O)OCC(CCCCCCCC)CCCCCCCCCC)CC(C)(C)C1 AWOTXJMTZAPRFT-UHFFFAOYSA-N 0.000 description 1
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ALKCLFLTXBBMMP-UHFFFAOYSA-N 3,7-dimethylocta-1,6-dien-3-yl hexanoate Chemical compound CCCCCC(=O)OC(C)(C=C)CCC=C(C)C ALKCLFLTXBBMMP-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HCLVXVIAGDXHTL-UHFFFAOYSA-N 4-(5-butyldodecan-5-yloxy)-3-hydroxy-4-oxobutanoic acid Chemical compound CCCCCCCC(CCCC)(CCCC)OC(=O)C(O)CC(O)=O HCLVXVIAGDXHTL-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- IUWVYVOQTFVXKL-UHFFFAOYSA-N 4-decyl-1,3-oxazolidin-2-one Chemical compound CCCCCCCCCCC1COC(=O)N1 IUWVYVOQTFVXKL-UHFFFAOYSA-N 0.000 description 1
- YMCIVAPEOZDEGH-UHFFFAOYSA-N 5-chloro-2,3-dihydro-1h-indole Chemical compound ClC1=CC=C2NCCC2=C1 YMCIVAPEOZDEGH-UHFFFAOYSA-N 0.000 description 1
- BIBSVSRJRVSBNF-MFERNQICSA-N 5-o-octadecanoyl 1-o-(9-octylicosan-9-yl) (2s)-2-aminopentanedioate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(CCCCCCCC)(CCCCCCCC)CCCCCCCCCCC BIBSVSRJRVSBNF-MFERNQICSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- GPZYYYGYCRFPBU-UHFFFAOYSA-N 6-Hydroxyflavone Chemical compound C=1C(=O)C2=CC(O)=CC=C2OC=1C1=CC=CC=C1 GPZYYYGYCRFPBU-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000379194 Abies sibirica Species 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 241000589218 Acetobacteraceae Species 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000203716 Actinomycetaceae Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 1
- 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606126 Bacteroidaceae Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 101000741307 Bothrops atrox Batroxicidin Proteins 0.000 description 1
- 101000741308 Bothrops lutzi Lutzicidin Proteins 0.000 description 1
- 241000131971 Bradyrhizobiaceae Species 0.000 description 1
- 241000249497 Brucellaceae Species 0.000 description 1
- GOJCZVPJCKEBQV-UHFFFAOYSA-N Butyl phthalyl butylglycolate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
- 241000644798 Canarium <sea snail> Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241001112722 Carnobacteriaceae Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- 241001142109 Chloroflexi Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 240000003791 Citrus myrtifolia Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241001430149 Clostridiaceae Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 208000037384 Clostridium Infections Diseases 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241001600130 Comamonadaceae Species 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 101000741306 Crotalus durissus cascavella Cathelicidin-related peptide isoform 3 Proteins 0.000 description 1
- 101000741303 Crotalus durissus terrificus Crotalicidin Proteins 0.000 description 1
- 229910000570 Cupronickel Inorganic materials 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 102000006375 Desmocollins Human genes 0.000 description 1
- 108010019063 Desmocollins Proteins 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N Diethylhexyl phthalate Natural products CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- UDSFAEKRVUSQDD-UHFFFAOYSA-N Dimethyl adipate Chemical compound COC(=O)CCCCC(=O)OC UDSFAEKRVUSQDD-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical class CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000244332 Flavobacteriaceae Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241001183186 Fusobacteriaceae Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000912243 Homo sapiens Beta-defensin 104 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 101150027725 IVL gene Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102100026236 Interleukin-8 Human genes 0.000 description 1
- 241001655312 Intrasporangiaceae Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 101000741319 Lachesis muta rhombeata Lachesicidin Proteins 0.000 description 1
- 241001112693 Lachnospiraceae Species 0.000 description 1
- 241001468155 Lactobacillaceae Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241001227551 Lavandula x intermedia Species 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 235000007421 Mentha citrata Nutrition 0.000 description 1
- 244000007703 Mentha citrata Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LOMVENUNSWAXEN-UHFFFAOYSA-N Methyl oxalate Chemical compound COC(=O)C(=O)OC LOMVENUNSWAXEN-UHFFFAOYSA-N 0.000 description 1
- 241000192017 Micrococcaceae Species 0.000 description 1
- 241000589289 Moraxellaceae Species 0.000 description 1
- 241000588656 Neisseriaceae Species 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241001655308 Nocardiaceae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 101000933753 Ophiophagus hannah Cathelicidin-related peptide Oh-Cath Proteins 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001275902 Parabramis pekinensis Species 0.000 description 1
- 241000606752 Pasteurellaceae Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241001112692 Peptostreptococcaceae Species 0.000 description 1
- CVXHBROPWMVEQO-UHFFFAOYSA-N Peroxyoctanoic acid Chemical compound CCCCCCCC(=O)OO CVXHBROPWMVEQO-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 241001112744 Planococcaceae Species 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920002593 Polyethylene Glycol 800 Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000692843 Porphyromonadaceae Species 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101000932958 Pseudonaja textilis Cathelicidin-related peptide Pt_CRAMP1 Proteins 0.000 description 1
- 101000741290 Pseudonaja textilis Cathelicidin-related peptide Pt_CRAMP2 Proteins 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 229910002808 Si–O–Si Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241001660099 Sphingobacteriaceae Species 0.000 description 1
- 241000131972 Sphingomonadaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001493533 Streptophyta Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 241001430183 Veillonellaceae Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001453327 Xanthomonadaceae Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 229940078576 acetyl triethylhexyl citrate Drugs 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- HIIPJZUJGNLWJQ-UHFFFAOYSA-N bis(14-methylpentadecyl) dodecanedioate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C HIIPJZUJGNLWJQ-UHFFFAOYSA-N 0.000 description 1
- UNZOESWLBMZBEY-JEIPZWNWSA-N bis(16-methylheptadecyl) (e)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C\C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-JEIPZWNWSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- ITIHYXREPVHWNY-UHFFFAOYSA-N bis(16-methylheptadecyl) decanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C ITIHYXREPVHWNY-UHFFFAOYSA-N 0.000 description 1
- GFRHRWJBYWRSJE-UHFFFAOYSA-N bis(16-methylheptadecyl) hexanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCCCCCCCC(C)C GFRHRWJBYWRSJE-UHFFFAOYSA-N 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- RWPICVVBGZBXNA-UHFFFAOYSA-N bis(2-ethylhexyl) benzene-1,4-dicarboxylate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C=C1 RWPICVVBGZBXNA-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- GJRRTUSXQPXVES-UHFFFAOYSA-N bis(2-methylpropyl) oxalate Chemical compound CC(C)COC(=O)C(=O)OCC(C)C GJRRTUSXQPXVES-UHFFFAOYSA-N 0.000 description 1
- WLRZTBZLAQJGJP-OKTFGQEQSA-N bis(2-octyldodecyl) (2s)-2-(dodecanoylamino)pentanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)[C@@H](NC(=O)CCCCCCCCCCC)CCC(=O)OCC(CCCCCCCC)CCCCCCCCCC WLRZTBZLAQJGJP-OKTFGQEQSA-N 0.000 description 1
- IHURUMZMADFAGS-VHXPQNKSSA-N bis(2-octyldodecyl) (Z)-hexatriacont-18-enedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCCC\C=C/CCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC IHURUMZMADFAGS-VHXPQNKSSA-N 0.000 description 1
- OOCBIZIRIHNNGC-UHFFFAOYSA-N bis(2-octyldodecyl) 2-hydroxybutanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CC(O)C(=O)OCC(CCCCCCCC)CCCCCCCCCC OOCBIZIRIHNNGC-UHFFFAOYSA-N 0.000 description 1
- VOKLGPGMRNGCOO-UHFFFAOYSA-N bis(2-octyldodecyl) decanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC VOKLGPGMRNGCOO-UHFFFAOYSA-N 0.000 description 1
- VTSODSKQIAGVCA-UHFFFAOYSA-N bis(2-octyldodecyl) dodecanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC VTSODSKQIAGVCA-UHFFFAOYSA-N 0.000 description 1
- WLFITRMCTPBSQS-UHFFFAOYSA-N bis(2-octyldodecyl) hexanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC WLFITRMCTPBSQS-UHFFFAOYSA-N 0.000 description 1
- FNQVCKJDSDFDTE-UHFFFAOYSA-N bis(3-methylbutyl) 2-hydroxybutanedioate Chemical compound CC(C)CCOC(=O)CC(O)C(=O)OCCC(C)C FNQVCKJDSDFDTE-UHFFFAOYSA-N 0.000 description 1
- ZWYAVGUHWPLBGT-UHFFFAOYSA-N bis(6-methylheptyl) decanedioate Chemical compound CC(C)CCCCCOC(=O)CCCCCCCCC(=O)OCCCCCC(C)C ZWYAVGUHWPLBGT-UHFFFAOYSA-N 0.000 description 1
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 description 1
- SNJKWPXWLBQHJA-UHFFFAOYSA-N bis[1-[1-(1-tetradecoxypropan-2-yloxy)propan-2-yloxy]propan-2-yl] hexanedioate Chemical compound CCCCCCCCCCCCCCOCC(C)OCC(C)OCC(C)OC(=O)CCCCC(=O)OC(C)COC(C)COC(C)COCCCCCCCCCCCCCC SNJKWPXWLBQHJA-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 210000004922 colonic epithelial cell Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- FOTKYAAJKYLFFN-UHFFFAOYSA-N decane-1,10-diol Chemical compound OCCCCCCCCCCO FOTKYAAJKYLFFN-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229940099822 di-ppg-2 myreth-10 adipate Drugs 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- HCQHIEGYGGJLJU-UHFFFAOYSA-N didecyl hexanedioate Chemical compound CCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCC HCQHIEGYGGJLJU-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 229940067572 diethylhexyl adipate Drugs 0.000 description 1
- 229940096810 diethylhexyl sebacate Drugs 0.000 description 1
- 229940105984 diethylhexyl succinate Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940116961 diisocetyl dodecanedioate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940114373 dipentaerythrityl hexa c5-10 acid esters Drugs 0.000 description 1
- ITHNIFCFNUZYLQ-UHFFFAOYSA-N dipropan-2-yl oxalate Chemical compound CC(C)OC(=O)C(=O)OC(C)C ITHNIFCFNUZYLQ-UHFFFAOYSA-N 0.000 description 1
- HZHMMLIMOUNKCK-UHFFFAOYSA-N dipropyl oxalate Chemical compound CCCOC(=O)C(=O)OCCC HZHMMLIMOUNKCK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 239000000294 eucalyptus globulus labille leaf/twig oil Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 238000009650 gentamicin protection assay Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 102000052624 human CXCL8 Human genes 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940031575 hydroxyethyl urea Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical class Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 150000004966 inorganic peroxy acids Chemical class 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 239000001289 litsea cubeba fruit oil Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 244000309711 non-enveloped viruses Species 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000001451 organic peroxides Chemical group 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- 229940061571 peg-9 dimethicone Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 1
- CZPZWMPYEINMCF-UHFFFAOYSA-N propaneperoxoic acid Chemical compound CCC(=O)OO CZPZWMPYEINMCF-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical group [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- TUUQISRYLMFKOG-UHFFFAOYSA-N trihexyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCOC(=O)CC(C(=O)OCCCCCC)(OC(C)=O)CC(=O)OCCCCCC TUUQISRYLMFKOG-UHFFFAOYSA-N 0.000 description 1
- 125000005591 trimellitate group Chemical group 0.000 description 1
- 229940047179 trimethylpentanediyl dibenzoate Drugs 0.000 description 1
- FRDNONBEXWDRDM-UHFFFAOYSA-N tris(2-ethylhexyl) 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)(OC(C)=O)CC(=O)OCC(CC)CCCC FRDNONBEXWDRDM-UHFFFAOYSA-N 0.000 description 1
- DUHIKWRPAQIIBL-UHFFFAOYSA-N tris(2-ethylhexyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCC(CC)COC(=O)CC(O)(C(=O)OCC(CC)CCCC)CC(=O)OCC(CC)CCCC DUHIKWRPAQIIBL-UHFFFAOYSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 229940124543 ultraviolet light absorber Drugs 0.000 description 1
- 229940075466 undecylenate Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662425699P | 2016-11-23 | 2016-11-23 | |
| US62/425,699 | 2016-11-23 | ||
| PCT/US2017/062784 WO2018098152A1 (en) | 2016-11-23 | 2017-11-21 | Sanitizer composition with probiotic/prebiotic active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3043748A1 true CA3043748A1 (en) | 2018-05-31 |
Family
ID=60766143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3043748A Abandoned CA3043748A1 (en) | 2016-11-23 | 2017-11-21 | Sanitizer composition with probiotic/prebiotic active ingredient |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11564879B2 (enExample) |
| EP (1) | EP3544575A1 (enExample) |
| JP (1) | JP2020500860A (enExample) |
| AU (1) | AU2017365019A1 (enExample) |
| CA (1) | CA3043748A1 (enExample) |
| WO (1) | WO2018098152A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物 |
| US11628129B2 (en) | 2017-04-04 | 2023-04-18 | Gojo Industries, Inc. | Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems |
| CA3128087A1 (en) * | 2019-01-29 | 2020-08-06 | Skinprotect Corporation Sdn Bhd | Synthetic elastomeric article and method for the production thereof |
| US20200368146A1 (en) * | 2019-05-22 | 2020-11-26 | Mary Ahern | Method of cosmetic preservation |
| FR3097436B1 (fr) * | 2019-06-24 | 2023-10-13 | Oreal | Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose |
| GR1009978B (el) * | 2019-12-20 | 2021-04-22 | Ossino, Maurizio Vittorio | Σκευασμα (γελη) τοπικης εφαρμογης για αντισηψια, απολυμανση και προστασια απο ιους, βακτηρια, μυκητες |
| TR202019409A1 (tr) * | 2020-12-01 | 2022-06-21 | Eczacibasi Tueketim Ueruenleri Sanayi Ve Ticaret Anonim Sirketi | Ci̇ldi̇n dezenfekte edi̇lmesi̇ni̇ sağlayan ve ci̇lt florasini destekleyen alkol bazli bi̇r ürün |
| CN113576943B (zh) * | 2021-07-09 | 2022-07-12 | 中山大学 | 一种益生元发酵物及其制备方法与应用 |
Family Cites Families (528)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1453447A (en) | 1972-09-06 | 1976-10-20 | Kimberly Clark Co | Nonwoven thermoplastic fabric |
| US4766029A (en) | 1987-01-23 | 1988-08-23 | Kimberly-Clark Corporation | Semi-permeable nonwoven laminate |
| ATE124860T1 (de) | 1989-07-28 | 1995-07-15 | Hisamitsu Pharmaceutical Co | Schaumaerosolzusammensetzung. |
| US5169706A (en) | 1990-01-10 | 1992-12-08 | Kimberly-Clark Corporation | Low stress relaxation composite elastic material |
| US5464688A (en) | 1990-06-18 | 1995-11-07 | Kimberly-Clark Corporation | Nonwoven web laminates with improved barrier properties |
| JPH05140597A (ja) * | 1991-11-25 | 1993-06-08 | Shieburesuto Japan:Kk | 皮膚用洗浄剤 |
| JP3045613B2 (ja) | 1992-06-24 | 2000-05-29 | 鐘紡株式会社 | 養毛化粧料 |
| US5269959A (en) * | 1992-09-16 | 1993-12-14 | Gary Schreibman | Liquid deep cleaning detergent composition |
| US5265772A (en) | 1992-10-19 | 1993-11-30 | Gojo Industries, Inc. | Dispensing apparatus with tube locator |
| JPH06287106A (ja) | 1993-04-01 | 1994-10-11 | Kanebo Ltd | 皮膚化粧料 |
| DE69431436T2 (de) | 1993-07-01 | 2003-07-31 | Tonejet Corp. Pty. Ltd., Eastwood | Flüssige tinte für den tintenstrahldruck |
| RU2142981C1 (ru) | 1993-09-14 | 1999-12-20 | Дзе Проктер Энд Гэмбл Компани | Удобная в эксплуатации жидкая или гелевая моющая композиция для мытья посуды и удобная в эксплуатации жидкая моющая композиция для мытья посуды |
| CA2177682C (en) | 1993-12-23 | 1999-12-28 | Sekhar Mitra | Antimicrobial wipe compositions |
| CA2196771A1 (en) | 1994-08-25 | 1996-02-29 | Laszlo Moldovanyi | Surface-active formulations |
| ZA962455B (en) | 1995-03-31 | 1996-10-02 | B Eugene Guthery | Fast acting and persistent topical antiseptic |
| US5942479A (en) | 1995-05-27 | 1999-08-24 | The Proctor & Gamble Company | Aqueous personal cleansing composition with a dispersed oil phase comprising two specifically defined oil components |
| DE19530816A1 (de) | 1995-08-23 | 1997-02-27 | Cognis Bio Umwelt | Verwendung von mutierter Subtilisin-Protease in kosmetischen Produkten |
| BR9602897A (pt) | 1996-06-26 | 1998-04-28 | Unilever Nv | Composição de barra de sab o |
| ATE281150T1 (de) | 1996-09-13 | 2004-11-15 | Univ Clemson | Mittel zur akne behandlung |
| US6221847B1 (en) * | 1996-09-13 | 2001-04-24 | Clemson University | Composition and method for treating bacterial infection |
| ATE256472T1 (de) | 1996-09-25 | 2004-01-15 | Gracelinc Ltd | Beta-glukan produkte und deren extraktionsverfahren aus cerealien |
| FR2754451B1 (fr) | 1996-10-14 | 1998-11-06 | Oreal | Creme auto-moussante |
| EP1629846B1 (en) | 1997-04-18 | 2010-12-29 | Ganeden Biotech, Inc. | Topical use of probiotic bacillus spores to prevent or control microbial infections |
| US7507402B1 (en) | 1997-04-18 | 2009-03-24 | Ganeden Biotech, Inc. | Topical use of probiotic Bacillus spores to prevent or control microbial infections |
| US6645506B1 (en) | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| US6716435B1 (en) | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
| FR2766478B1 (fr) | 1997-07-23 | 1999-09-03 | Inst Francais Du Petrole | Procede de traitement bacterien d'effluents contenant de l'ethyl-tert-butyl ether |
| DE19748921C2 (de) | 1997-10-30 | 2001-02-22 | Stockhausen Chem Fab Gmbh | Hautverträgliche Handreiniger, insbesondere Grobhandreiniger |
| US6036946A (en) | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
| JP3763075B2 (ja) | 1998-04-24 | 2006-04-05 | サンスター株式会社 | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
| US5944227A (en) | 1998-07-06 | 1999-08-31 | Gojo Industries, Inc. | Dispenser for multiple cartridges |
| FR2781669B1 (fr) | 1998-07-31 | 2000-09-15 | Lanatech | Composition cosmetique incluant au moins un polysaccharide provenant de bacteries d'origine hydrothermale |
| US6071541A (en) | 1998-07-31 | 2000-06-06 | Murad; Howard | Pharmaceutical compositions and methods for managing skin conditions |
| US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| US6358516B1 (en) | 1998-08-21 | 2002-03-19 | Norris R. Harod | One-step system for cleansing, conditioning, and treating the skin |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| EP1121098A2 (en) | 1998-10-13 | 2001-08-08 | Johnson & Johnson Consumer Companies, Inc. | Cream cleanser with high levels of emollients and glycerin |
| JP2000143513A (ja) | 1998-11-16 | 2000-05-23 | Taisho Pharmaceut Co Ltd | 外用組成物 |
| US6423329B1 (en) | 1999-02-12 | 2002-07-23 | The Procter & Gamble Company | Skin sanitizing compositions |
| US6760331B1 (en) | 1999-03-31 | 2004-07-06 | Cisco Technology, Inc. | Multicast routing with nearest queue first allocation and dynamic and static vector quantization |
| US7452545B2 (en) | 2001-11-13 | 2008-11-18 | Yu Ruey J | Oligosaccharide aldonic acids and their topical use |
| ATE270558T1 (de) | 1999-08-26 | 2004-07-15 | Ganeden Biotech Inc | Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien |
| CA2389982C (en) * | 1999-11-08 | 2015-06-16 | Ganeden Biotech, Inc. | Inhibition of pathogens by bacillus coagulans strains |
| US6849256B1 (en) | 1999-11-08 | 2005-02-01 | Ganeden Biotech Incorporated | Inhibition of pathogens by probiotic bacteria |
| US6877642B1 (en) | 2000-01-04 | 2005-04-12 | Joseph S. Kanfer | Wall-mounted dispenser for liquids |
| JP2004521067A (ja) | 2000-06-28 | 2004-07-15 | サンダース,イラ | 動物(哺乳動物)における有用な用途を目的とする破傷風毒素の使用方法 |
| EP1170015A1 (de) | 2000-07-06 | 2002-01-09 | Laboratoires Serobiologiques(Societe Anonyme) | Verwendung von Extrakten des Pilzes Grifola frondosa |
| FR2811228B1 (fr) | 2000-07-07 | 2002-10-25 | Lvmh Rech | Utilisation d'oligosaccharides ou d'extraits de plantes en contenant comme agent cosmetique ou dermatologique notamment pour stimuler la production de beta-endorphine dans la peau |
| US6461857B1 (en) | 2000-07-19 | 2002-10-08 | Arch Personal Care Products, L.P. | Producing water-soluble yeast extract by adding peroxide to growing yeast cells |
| CN1267212C (zh) | 2000-08-11 | 2006-08-02 | 大卫·R·怀特洛克 | 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品 |
| AU2001295469A1 (en) | 2000-08-18 | 2002-03-04 | Bitop Gesellschaft Fur Biotechnische Optimierung Mbh | Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols |
| CN100553646C (zh) | 2000-10-06 | 2009-10-28 | 雀巢产品股份有限公司 | 用乳酸菌微生态制剂调节皮肤免疫系统 |
| WO2002045727A1 (en) | 2000-12-08 | 2002-06-13 | Plbio Co., Ltd. | Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa |
| EP1344528B1 (en) | 2000-12-19 | 2008-10-08 | Kabushiki Kaisha Yakult Honsha | External skin preparations and process for producing the same |
| FR2819404B1 (fr) | 2001-01-12 | 2004-11-05 | Oreal | Compositions cosmetiques contenant un fructane et un polymere cationique et leurs utilisations |
| FR2819403B1 (fr) | 2001-01-12 | 2004-10-15 | Oreal | Compositions cosmetiques contenant un fructane, un polysaccharide et un agent benefique et leurs utilisations |
| CA2338124C (en) | 2001-02-26 | 2010-08-03 | Valerie Dumont Dicianna | Self-tanning composition in sheeted substrate |
| FR2822163B3 (fr) | 2001-03-16 | 2003-06-13 | Centre Nat Rech Scient | Molecules d'acides nucleiques codant une dextrane-saccharase catalysant la synthese de dextrane portant des ramifications de type alpha-1,2 osidiques |
| US6509007B2 (en) | 2001-03-19 | 2003-01-21 | The Procter & Gamble Company | Oral care kits and compositions |
| US7611882B2 (en) | 2001-05-14 | 2009-11-03 | Novozymes A/S | Detergent compositions comprising Bacillus subtilis pectate lyases |
| EP1260227A1 (en) | 2001-05-23 | 2002-11-27 | Societe Des Produits Nestle S.A. | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| US6436892B1 (en) | 2001-07-12 | 2002-08-20 | Colgate-Palmolive Company | Cleaning wipe comprising 2 bromo-2 nitropropane-1,3 diol |
| US6495508B1 (en) | 2001-07-12 | 2002-12-17 | Colgate-Palmolive Company | Cleaning wipe |
| US6410499B1 (en) | 2001-07-12 | 2002-06-25 | Colgate-Palmolive Co. | Antibacterial cleaning wipe comprising ammonium salt disenfectant |
| SE0102864D0 (sv) | 2001-08-29 | 2001-08-29 | Svenska Miljoebolaget Svv Ab | Antimicrorobial agent |
| US7241452B2 (en) | 2001-09-20 | 2007-07-10 | Stockhausen Gmbh & Co. Kg | Skin and hair care agents |
| DE10147100A1 (de) | 2001-09-25 | 2003-04-17 | Numico Res B V | Antiinfektive Kohlenhydrate |
| JP2005509052A (ja) | 2001-10-23 | 2005-04-07 | インノゲル アクチエンゲゼルシャフト | 多糖類を基剤とする網状構造およびその製造方法 |
| EP1453909B1 (en) | 2001-12-11 | 2007-10-03 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
| US20030143262A1 (en) | 2001-12-13 | 2003-07-31 | Brusk Ulla Forsgren | Hygiene tissue |
| EP1455802B1 (en) | 2001-12-14 | 2008-10-15 | Dnp Canada Inc. | Uses of chitosan oligosaccharides |
| US6673755B2 (en) | 2002-01-16 | 2004-01-06 | The Procter & Gamble Company | Personal cleansing compositions containing cleansing and skin active phases separated by one or more packaging barriers |
| US6797683B2 (en) | 2002-03-04 | 2004-09-28 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Ordered liquid crystalline cleansing composition with benefit agent particles |
| EP1489924A2 (en) | 2002-03-12 | 2004-12-29 | Council Of Scientific And Industrial Research | Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| AU2003226609A1 (en) | 2002-04-18 | 2003-10-27 | Right After - Advanced Hygiene Solutions Ltd. | A compound for cleansing the skin and a product impregnated therewith |
| FR2839516B1 (fr) | 2002-05-13 | 2006-08-04 | Pierre Bruno Grascha | Formulation de detergent d'atelier |
| US7217417B2 (en) | 2002-05-20 | 2007-05-15 | Dermacia, Inc. | Gel-based cosmetic and wound-healing formulation and method |
| US8361450B2 (en) | 2002-06-04 | 2013-01-29 | The Procter & Gamble Company | Shampoo containing a gel network and a non-guar galactomannan polymer derivative |
| CN101172091B (zh) | 2007-09-25 | 2011-04-27 | 北京美福源生物医药科技有限公司 | 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途 |
| DE10231468A1 (de) | 2002-07-08 | 2004-02-26 | Coty B.V. | Anti-Hautalterungskosmetikum |
| AU2003257143A1 (en) | 2002-07-31 | 2004-02-16 | Shaklee Corporation | A method for maximizing scalp health and inducing enhanced visual and tactile hair quality |
| FR2843125B1 (fr) | 2002-08-02 | 2012-11-16 | Coletica | Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs |
| US6787511B2 (en) | 2002-08-14 | 2004-09-07 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Biphasic composition induced by polydextrose |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20120156144A1 (en) | 2002-10-25 | 2012-06-21 | Foamix | Foamable Compositions, Kits and Methods for Hyperhidrosis |
| KR100828468B1 (ko) | 2002-11-04 | 2008-05-13 | 더 프록터 앤드 갬블 캄파니 | 개선된 안정성을 갖는 세정 상 및 개별적인 보호 상을포함하는 스트라이프형 액체 개인 세정 조성물 |
| US6924256B2 (en) | 2002-11-08 | 2005-08-02 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Liquid cleansing composition having simultaneous exfoliating and moisturizing properties |
| AU2003297317A1 (en) | 2002-12-13 | 2004-07-09 | Case Western Reserve University | Defensin-inducing peptides from fusobacterium |
| SE525647C2 (sv) | 2003-01-03 | 2005-03-29 | Sca Hygiene Prod Ab | Hygientissue för rengöring av och överföring av mjölksyraproducerande bakterier till huden och det urogenitila området |
| CN100341521C (zh) | 2003-03-07 | 2007-10-10 | 奥力有限公司 | 含β-葡聚糖的组合物 |
| CN101941668B (zh) | 2003-03-21 | 2013-01-02 | 约瑟夫·坎弗 | 无需用手致动的用于分配一定量物质的装置 |
| US20040243076A1 (en) | 2003-05-13 | 2004-12-02 | Sca Hygiene Products Ab | Hygiene product with a probiotic composition |
| FR2854824B1 (fr) | 2003-05-16 | 2005-07-08 | Clean 3 Bio System | Procede et installation pour le nettoyage de pieces souillees par de la matiere organique par bio-depollution |
| US7776346B2 (en) | 2003-05-22 | 2010-08-17 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal product compositions comprising structured benefit agent premix or delivery vehicle |
| US7560125B2 (en) | 2003-05-22 | 2009-07-14 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced deposition of hydrophilic benefit agent |
| FR2855968B1 (fr) | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques |
| US20050075497A1 (en) | 2003-06-20 | 2005-04-07 | Ferdinand Utz | Hydrocolloids and process therefor |
| DE102004011968A1 (de) * | 2004-03-10 | 2005-09-29 | Henkel Kgaa | Präbiotisch wirksame Pflanzenextrakte |
| US20050063932A1 (en) | 2003-08-14 | 2005-03-24 | Natalie Dilallo | Skin care compositions including hexapeptide complexes and methods of their manufacture |
| DE10339163A1 (de) | 2003-08-26 | 2005-03-24 | Henkel Kgaa | Milde Bleichmittel mit erhöhter Aufhellleistung |
| DE10340543A1 (de) | 2003-09-01 | 2005-03-24 | Henkel Kgaa | Mund- und Zahnpflegemittel |
| EP1671629A4 (en) | 2003-09-19 | 2008-11-26 | Otsuka Pharma Co Ltd | HUMAN BETA DEFENSIN SECRETION AMPLIFIER |
| US7758878B2 (en) | 2003-10-10 | 2010-07-20 | Access Business Group International Llc | Cosmetic treatment system and methods |
| IE20030773A1 (en) | 2003-10-17 | 2005-04-20 | Teagasc Agric Food Dev Authori | Use of probiotic bacteria in the treatment of infection |
| KR100552245B1 (ko) | 2003-10-24 | 2006-02-14 | 주식회사 코리아나화장품 | 예덕나무 추출물을 함유하는 주름 개선 화장료 조성물 |
| SE528537C2 (sv) | 2003-11-24 | 2006-12-12 | Biovelop Internat Bv | Löslig dietfiber från havre- och kornsädeskorn |
| EP1541117A1 (en) | 2003-12-12 | 2005-06-15 | Tiense Suikerraffinaderij N.V. | Cosmetic rinse-off compositions comprising inulin-type fructan |
| US7028861B2 (en) | 2003-12-16 | 2006-04-18 | Joseph S. Kanfer | Electronically keyed dispensing systems and related methods of installation and use |
| US20050137102A1 (en) | 2003-12-17 | 2005-06-23 | Kimberly-Ckark Worldwide, Inc. | Foamable industrial strength hand cleanser |
| US8337915B2 (en) | 2004-01-10 | 2012-12-25 | S George Aburdeineh | Fenugreek seed extract to lower blood cholesterol |
| KR20060132709A (ko) | 2004-01-30 | 2006-12-21 | 도호 가가꾸 고오교 가부시키가이샤 | 양이온 변성 정제 갈락토만난 다당 및 상기 물질을포함하는 화장료 조성물 |
| WO2005091933A2 (en) | 2004-03-04 | 2005-10-06 | E-L Management Corporation | Skin treatment method with lactobacillus extract |
| US6844308B1 (en) | 2004-04-16 | 2005-01-18 | Colgate-Palmolive Company | Antibacterial cleaning wipe |
| US7666824B2 (en) | 2004-04-22 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Liquid cleanser compositions |
| GB0410785D0 (en) | 2004-05-14 | 2004-06-16 | Glycologic Ltd | Improved prebiotic |
| EP1600061B1 (en) | 2004-05-25 | 2010-05-12 | Cognis IP Management GmbH | Oral and/or topical compositions |
| EP1600060A1 (en) | 2004-05-25 | 2005-11-30 | Cognis IP Management GmbH | Oral and/or topical compositions comprising prebiotics and fatty acid |
| EP1600062A1 (en) | 2004-05-25 | 2005-11-30 | Cognis IP Management GmbH | Oral and/or topical compositions comprising prebiotics and sterols |
| GB2414666B (en) | 2004-06-03 | 2009-01-07 | James Steven Brown | Sanitizing composition and method of preparation |
| MXPA06015184A (es) | 2004-06-23 | 2007-11-22 | Nestec Sa | Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas. |
| MX2007001098A (es) | 2004-07-28 | 2009-02-11 | Raymond M Pleva | Composicion de aceite de emu y fruta. |
| ITMI20041550A1 (it) | 2004-07-29 | 2004-10-29 | Proge Farm Srl | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide |
| DE102004037505A1 (de) | 2004-08-03 | 2006-02-23 | Henkel Kgaa | Präbiotische Intimpflege |
| JP4268105B2 (ja) | 2004-09-09 | 2009-05-27 | 株式会社アウレオ | β−グルカン含有組成物、その製造方法及び該組成物を含む飲食品若しくは皮膚用保湿剤 |
| JP5112069B2 (ja) | 2004-10-04 | 2013-01-09 | ロレアル | 敏感肌のための化粧品及び/または皮膚科組成物 |
| US9198847B2 (en) | 2004-11-05 | 2015-12-01 | The Procter & Gamble Company | Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system |
| JP4457303B2 (ja) | 2004-12-14 | 2010-04-28 | 清水化学株式会社 | グルコマンナンゲル粒子の製造法 |
| US7621426B2 (en) | 2004-12-15 | 2009-11-24 | Joseph Kanfer | Electronically keyed dispensing systems and related methods utilizing near field frequency response |
| US7803746B2 (en) | 2004-12-16 | 2010-09-28 | Georgia-Pacific Consumer Products Lp | Antimicrobial foam hand soap comprising inulin or an inulin surfactant |
| JP5722282B2 (ja) | 2004-12-24 | 2015-05-20 | 株式会社明治 | 皮膚改善剤及び皮膚改善方法 |
| US20060140899A1 (en) | 2004-12-28 | 2006-06-29 | Kimberly-Clark Worldwide, Inc. | Skin cleansing system comprising an anti-adherent formulation and a cationic compound |
| WO2006069953A1 (en) | 2004-12-29 | 2006-07-06 | Symrise Gmbh & Co. Kg | Use of synergistically active 1, 2-alkanediol mixtures as skin moisture-regulating compositions |
| FR2880802B1 (fr) | 2005-01-14 | 2008-12-19 | Sederma Soc Par Actions Simpli | Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene |
| GB0501365D0 (en) | 2005-01-21 | 2005-03-02 | Promar As | Compositions |
| CA2533950C (en) | 2005-01-28 | 2013-10-22 | B. Braun Medical Ag | Virucidal disinfectant |
| KR100479719B1 (ko) | 2005-01-29 | 2005-03-31 | 주식회사 프로바이오닉 | 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Probio-65 |
| US20060204466A1 (en) | 2005-03-08 | 2006-09-14 | Ecolab Inc. | Hydroalcoholic antimicrobial composition with skin health benefits |
| US8778863B2 (en) | 2005-03-17 | 2014-07-15 | Caper Naum Vista Olive Oil Market Ltd. | Soaps from organic residues and method of producing the same |
| NZ539076A (en) | 2005-03-29 | 2008-05-30 | Blis Technologies Ltd | Skin treatment compositions |
| FR2883884B1 (fr) | 2005-03-30 | 2012-11-09 | Lallemand Sas | Preparation de levures a proprietes anti-oxydantes ameliorees et leurs applications |
| WO2006110631A1 (en) | 2005-04-08 | 2006-10-19 | The Procter & Gamble Company | Methods of use of orally administered probiotic bifidobacteria for human beauty benefits |
| AR056313A1 (es) | 2005-04-15 | 2007-10-03 | Bayer Cropscience Gmbh | Inulina de cadena larga |
| EP1877031A2 (en) | 2005-05-04 | 2008-01-16 | The Procter and Gamble Company | Hair colouring kits and methods of use thereof |
| DE602006006995D1 (de) | 2005-05-04 | 2009-07-09 | Coty Prestige Lancaster Group | Verwendung von freien radikalfängern zum schutz und zur behandlung von durch chemotherapie verursachten haut- und haarschäden |
| CN101184780B (zh) | 2005-05-05 | 2012-10-03 | 森馨香料公司 | β-葡聚糖和甘露聚糖的制备 |
| US20060251634A1 (en) | 2005-05-06 | 2006-11-09 | Ho-Jin Kang | Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| US8173143B2 (en) | 2005-06-02 | 2012-05-08 | Tecco Michelle A | Personal skin care compositions containing anti-flammatory and anti-microbial agents |
| HUP0500582A1 (hu) | 2005-06-13 | 2007-08-28 | Csaba Jozsef Dr Jaszberenyi | Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok |
| WO2007001904A2 (en) | 2005-06-21 | 2007-01-04 | The Procter & Gamble Company | Personal care compositions comprising alpha-glucans and/or beta-glucans |
| EP1736537A1 (en) | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
| KR101221239B1 (ko) | 2005-07-07 | 2013-01-11 | (주)바이오벤 | 녹두 유산균 배양물 및 이의 제조방법, 그리고 이를함유하는 화장료 조성물 |
| DE102005033954A1 (de) | 2005-07-20 | 2007-01-25 | Switzerland c/o Laris Fiduciara Sca, Ethios | Zusammensetzung, die eine liposomale Dispersion von SiO2-Nanopartikeln und ein ß-1,3-verknüpftes Glucanetherderivat umfasst |
| US20090011042A1 (en) | 2005-07-26 | 2009-01-08 | Global Life Technologies, Corp | Antimicrobial and antiviral composition |
| US8999406B2 (en) * | 2005-07-26 | 2015-04-07 | Global Life Technologies Corp. | Antimicrobial and antiviral composition |
| US9463212B2 (en) | 2005-07-26 | 2016-10-11 | Global Life Technologies Corp. | Antimicrobial and antiviral composition |
| CA2617133C (en) | 2005-07-28 | 2014-09-30 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
| US20070027119A1 (en) | 2005-07-29 | 2007-02-01 | Ahmed Fahim U | Antibacterial composition and method of use |
| CA2617219A1 (en) | 2005-07-29 | 2007-02-01 | Suntory Limited | Compositions comprising fucoidan or a fucoidan hydrolysate and an immuno-stimulating material |
| FR2889057B1 (fr) | 2005-08-01 | 2008-07-18 | Oreal | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches |
| RU2459864C2 (ru) | 2005-09-13 | 2012-08-27 | Басф Се | Микроорганизмы, ингибирующие образование неприятного подмышечного запаха |
| BRPI0616049A2 (pt) | 2005-09-16 | 2011-06-07 | Reckitt Benckiser Inc | composições tópicas espumantes |
| EP1934328A1 (en) | 2005-09-19 | 2008-06-25 | Basf Se | Microorganisms inhibiting the formation of foot malodor |
| JP4876500B2 (ja) | 2005-09-22 | 2012-02-15 | 日油株式会社 | ゲル状手指消毒剤 |
| JP5001847B2 (ja) | 2005-09-27 | 2012-08-15 | 旭化成ケミカルズ株式会社 | セロオリゴ糖含有組成物 |
| US8246946B2 (en) | 2005-09-27 | 2012-08-21 | Cobb & Associates | Treatment of bipolar disorder utilizing anti-fungal compositions |
| US8053005B2 (en) | 2005-10-07 | 2011-11-08 | Global Life Technologies Corp. | Composition for controlling the respiratory effect of inhaled pollutants and allergens |
| US7632527B2 (en) | 2005-11-01 | 2009-12-15 | Juice Beauty | Compositions for juice-based peels and masks |
| US8318659B2 (en) | 2005-11-15 | 2012-11-27 | E I Du Pont De Nemours And Company | Peptide-based organic sunscreens |
| JP4800015B2 (ja) | 2005-11-22 | 2011-10-26 | 株式会社カロッツェリアジャパン | 皮膚炎発症抑制のための微生物培養物並びにそれらを用いた製品 |
| BRPI0619269A2 (pt) | 2005-11-30 | 2011-09-20 | Ciba Holding Inc | composição antibacteriana para contato com a mucosa ou outros tecidos da cavidade oral, composição para cuidados orais, uso de um escleroglucano, processo para preparação de uma formulação cosmética ou dermatológica, concentrado e, método de reduzir o número de bactérias e/ou minimizar a adesão de bactérias na mucosa oral |
| GB0524873D0 (en) | 2005-12-06 | 2006-01-11 | New Royal Holloway & Bedford | Bacterial production of carotenoids |
| US20070148101A1 (en) | 2005-12-28 | 2007-06-28 | Marcia Snyder | Foamable alcoholic composition |
| MX2008013708A (es) | 2006-04-28 | 2008-11-06 | Bayer Cropscience Ag | Inulina de cadena muy larga. |
| US8163715B2 (en) | 2006-04-28 | 2012-04-24 | Bayer Cropscience Ag | Inulin of very high chain length |
| DE102006021401A1 (de) | 2006-05-08 | 2007-12-13 | Henkel Kgaa | Amadoriasen in Wasch- und Reinigungsmitteln |
| US8703443B2 (en) | 2006-05-23 | 2014-04-22 | Toyo Boseki Kabushiki Kaisha | γ-L-PGA producing microorganism, method of producing γ-L-PGA using the microorganism, crosslinked substance produced using the microorganism, and external dermal agent produced using the microorganism |
| AU2007266675B2 (en) | 2006-05-28 | 2012-09-06 | Cipla-Medpro (Pty) Ltd | Probiotic strain and antimicrobial peptide derived therefrom |
| US7429292B2 (en) | 2006-06-15 | 2008-09-30 | Sun Chemical Corporation | Water washable lithographic printing ink |
| WO2008015343A2 (fr) | 2006-08-03 | 2008-02-07 | Societe D'extraction Des Principes Actifs Sa (Vincience) | Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes |
| US8114658B2 (en) | 2006-08-10 | 2012-02-14 | House Wellness Foods Corporation | Method of moisturizing skin |
| WO2008021441A2 (en) | 2006-08-15 | 2008-02-21 | Fitchmun Mark I | Surface sanitizer |
| ES2764221T3 (es) | 2006-08-24 | 2020-06-02 | Nestle Sa | Absorción duradera de flavonoides |
| JP5324220B2 (ja) | 2006-08-30 | 2013-10-23 | 株式会社ヤクルト本社 | シワ形成抑制剤 |
| WO2008040516A2 (de) | 2006-10-02 | 2008-04-10 | Georg Fritzmeier Gmbh & Co. Kg | Mikrobiologische zusammensetzung und deren verwendung |
| KR20080033705A (ko) | 2006-10-13 | 2008-04-17 | (주)아모레퍼시픽 | 캄페롤-3-o-루티노사이드의 제조방법 |
| JP2008099632A (ja) | 2006-10-20 | 2008-05-01 | Kyushu Univ | 免疫賦活作用・抗アレルギー作用を有する乳酸菌 |
| JP5362179B2 (ja) | 2006-10-20 | 2013-12-11 | 日清オイリオグループ株式会社 | ポリオキシエチレンソルビトール脂肪酸エステル及びそれを含有する水系ワックス分散物 |
| JP2008105983A (ja) | 2006-10-25 | 2008-05-08 | Nicca Chemical Co Ltd | 線維芽細胞増殖促進剤、皮膚外用剤、浴用剤及び飲食物 |
| US20080107699A1 (en) | 2006-10-25 | 2008-05-08 | Mark Spigelman | Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
| RU2009120880A (ru) | 2006-11-03 | 2010-12-10 | Геркулес Инкорпорейтед (Us) | Диспергируемые обработанные неборатной солью металла или хелатом полигалактоманнановые полимеры для применения в персональном средстве ухода и средстве ухода бытового применения |
| FR2908306B1 (fr) | 2006-11-09 | 2010-08-20 | Caster | Composition cosmetique a base de filtres solaires et d'un polysaccharide particulier |
| JP4102416B2 (ja) | 2006-11-15 | 2008-06-18 | 丸石製薬株式会社 | ゲル状殺菌消毒用組成物 |
| CN101568638B (zh) | 2006-11-17 | 2013-01-16 | Sca卫生用品公司 | 发酵乳杆菌Ess-1 DSM17851及其在治疗和/或预防念珠菌病以及尿道感染中的应用 |
| AU2006350772C1 (en) | 2006-11-17 | 2013-05-23 | Essity Hygiene And Health Aktiebolag | Hygiene tissue comprising a microbe-inhibiting composition |
| CN109010899A (zh) | 2006-11-17 | 2018-12-18 | Sca卫生用品公司 | 包含微生物抑制性组合物的卫生用品 |
| FR2908771B1 (fr) | 2006-11-20 | 2011-07-29 | Kitozyme Sa | Chitine-glucane d'extrait fongique de granulometrie fine |
| US20080124286A1 (en) | 2006-11-28 | 2008-05-29 | Lisson Jerold B | Algae supplement and treatment method |
| BRPI0719431A2 (pt) | 2006-12-01 | 2013-12-03 | Organobalance Gmbh | Composição, kit, uso de uma combinação de microorganismo, e, método para a produção da composição ou do kit. |
| JP2008179601A (ja) | 2006-12-28 | 2008-08-07 | Suntory Ltd | ラクトバチルス属菌を含む美容組成物 |
| JP5053667B2 (ja) | 2006-12-28 | 2012-10-17 | 日清ファルマ株式会社 | 新規乳酸菌および脂肪細胞分化促進用乳酸菌発酵産物 |
| JP5270122B2 (ja) | 2007-01-16 | 2013-08-21 | 株式会社ピカソ美化学研究所 | 酸性ムコ多糖産生微生物、酸性ムコ多糖の製造法、ならびに酸性ムコ多糖を有効成分として配合した美白剤 |
| FR2912055B1 (fr) | 2007-02-06 | 2009-05-15 | Idenov Lab | Composition cosmetique comprenant des actifs anti-inflammatoires, reparateurs, apaisants et hydratants pour calmer l'irritation de la peau |
| FR2912916B1 (fr) | 2007-02-26 | 2009-05-22 | Oreal | Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire |
| JP2008212111A (ja) | 2007-03-07 | 2008-09-18 | Somar Corp | 穀物粒及びこれを用いた穀粉、全粒粉、食品、動物用飼料、シロップ及びその製造方法、並びに、単離抽出したβ‐グルカンを含有する食品、添加剤、皮膚外用剤、医薬組成物及びその製造方法 |
| WO2008110672A1 (fr) | 2007-03-12 | 2008-09-18 | L'oreal | Utilisation d'un derive c-glycoside a titre d'agent anti-oxydant |
| EP2123290A1 (en) | 2007-03-19 | 2009-11-25 | Mizkan Group Corporation | Melanogenesis inhibitory composition |
| US20080233075A1 (en) | 2007-03-22 | 2008-09-25 | Marina Sokolinsky | Cosmetic composition for skin tightening |
| US8544698B2 (en) | 2007-03-26 | 2013-10-01 | Gojo Industries, Inc. | Foam soap dispenser with stationary dispensing tube |
| FR2914189A1 (fr) | 2007-03-26 | 2008-10-03 | Oreal | Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau. |
| WO2008119012A2 (en) | 2007-03-27 | 2008-10-02 | The Procter & Gamble Company | Methods and kits for administering probiotics |
| WO2008119556A2 (en) | 2007-04-03 | 2008-10-09 | Medizinische Universität Wien | A process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract |
| US9107920B2 (en) | 2007-04-13 | 2015-08-18 | V-Biotek Holding Aps | Extract of Trigonella foenum-graecum |
| CN101932719B (zh) | 2007-04-26 | 2014-04-02 | 株式会社林原 | 支链α-葡聚糖及生成其的α-葡糖基转移酶和它们的制造方法以及用途 |
| FR2915388B1 (fr) | 2007-04-27 | 2010-12-24 | Oreal | Film hydrosoluble cosmetique |
| US8333954B2 (en) | 2007-04-30 | 2012-12-18 | Kimberly-Clark Worldwide, Inc. | Foamable sanitizing compositions |
| PL2142635T3 (pl) | 2007-05-03 | 2019-01-31 | Tobias Olofsson | Nowe szczepy bakterii wyizolowane z przewodu wytwarzania miodu u pszczół miodnych |
| FR2915898B1 (fr) | 2007-05-10 | 2009-06-12 | Oreal | Procede de preparation d'actifs sur eau thermale et compositions les contenant |
| EP2146680B1 (en) | 2007-05-10 | 2011-10-19 | L'Oréal | Cosmetic composition comprising an inulin derivative in the form of an emulsion expanded in volume |
| CH696838A5 (it) | 2007-05-29 | 2007-12-31 | Labo Cosprophar Ag | Composizione cosmetica ad effetto lifting per sostenere tessuti cutanei rilassati. |
| FR2916634B1 (fr) | 2007-06-01 | 2009-10-02 | Jean Noel Thorel | Association synergique vis-a-vis de la flore microbienne de l'epiderme humain et applications cosmetiques et pharmaceutiques |
| JP5207664B2 (ja) | 2007-06-04 | 2013-06-12 | 株式会社シャネル化粧品技術開発研究所 | 化粧品 |
| FR2916977A1 (fr) | 2007-06-06 | 2008-12-12 | Engelhard Lyon Sa | STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE. |
| JP2008308478A (ja) | 2007-06-15 | 2008-12-25 | Hiroaki Rikihisa | 着色用皮膚外用組成物または日焼け止め用皮膚外用組成物の作成方法及び着色用皮膚外用組成物または日焼け止め用皮膚外用組成物。 |
| US20080160043A1 (en) | 2007-07-16 | 2008-07-03 | Kim Moo-Sung | Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same |
| FR2918884B1 (fr) | 2007-07-17 | 2010-01-15 | Oreal | Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur |
| FR2918886B1 (fr) | 2007-07-17 | 2010-01-08 | Oreal | Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles |
| FR2918883B1 (fr) | 2007-07-17 | 2010-01-15 | Oreal | Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches |
| ITRM20070398A1 (it) | 2007-07-17 | 2009-01-18 | Giuliani Spa | Procedimento per la preparazione di acido gamma-ammino butirrico (gaba) mediante batteri lattici (lab) su surplus agro-alimentari. |
| CN101754778B (zh) | 2007-07-19 | 2012-04-18 | Shl集团有限责任公司 | 用于传送药物的自动装置 |
| US8257753B2 (en) | 2007-07-20 | 2012-09-04 | Isp Investments Inc. | Use of an active principle originating from flax in a composition intended to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions |
| FR2918893B1 (fr) | 2007-07-20 | 2012-10-19 | Vincience | Utilisation d'un principe actif issu du lin pour preparer une composition destinee a activer le cytochrome c |
| SG174111A1 (en) | 2007-07-31 | 2011-10-28 | Phyto Pharma Pte Ltd | NOVEL ß-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE |
| AU2008293896B2 (en) | 2007-08-29 | 2014-10-02 | Ganeden Biotech, Inc. | Baked goods |
| US20110177140A1 (en) | 2007-08-31 | 2011-07-21 | Rainer Voegeli | 4-amidino benzylamines for cosmetic and/or dermatological use |
| FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
| MX2010002247A (es) | 2007-09-04 | 2010-05-17 | Oreal | Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel. |
| FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
| FR2920307B1 (fr) | 2007-09-04 | 2010-06-04 | Oreal | Utilisation cosmetique de microorganismes. |
| FR2920306B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation cosmetique d'un lysat de bifidobacterieum species. |
| US20090068219A1 (en) | 2007-09-10 | 2009-03-12 | 3Lab, Inc. | Anti-wrinkle hormone-type cosmetic composition |
| CN100566701C (zh) | 2007-09-18 | 2009-12-09 | 陈苏莉 | 一种含有黄姜和亚麻籽提取物的霜剂及其制备方法 |
| WO2009038778A1 (en) | 2007-09-19 | 2009-03-26 | Technology Holding, Llc | Topical product containing sacrificial material for neutralizing free radicals |
| FR2921260B1 (fr) | 2007-09-25 | 2012-08-24 | Lesaffre & Cie | Utilisation d'un nouvel agent naturel dans des compositions cosmetiques |
| US7862822B2 (en) | 2007-09-25 | 2011-01-04 | Elc Management Llc | Extracts from black yeast for whitening skin |
| JP4596373B2 (ja) | 2007-10-01 | 2010-12-08 | 株式会社 スイスロワール | 保湿効果を有する低粘性化グルコマンナン含有組成物の製造方法 |
| CZ303471B6 (cs) | 2007-10-03 | 2012-10-03 | Contipro Biotech S.R.O. | Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan |
| FR2921795B1 (fr) | 2007-10-03 | 2011-04-29 | Gervais Danone Sa | Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique |
| US20110182863A1 (en) | 2007-10-04 | 2011-07-28 | Ying Jia | Anti-bacteria compositions |
| FR2922450B1 (fr) | 2007-10-19 | 2014-06-13 | Lallemand Sas | Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees |
| US8119367B2 (en) | 2007-10-22 | 2012-02-21 | University Of Florida Research Foundation, Inc. | Nucleic acids, compositions and uses thereof |
| US8859627B2 (en) | 2007-10-23 | 2014-10-14 | Wild Child | Anti-microbial composition |
| US7618801B2 (en) | 2007-10-30 | 2009-11-17 | Danison US Inc. | Streptomyces protease |
| WO2009066537A1 (ja) | 2007-11-19 | 2009-05-28 | Meiji Dairies Corporation | 免疫調節性機能誘導剤及び食品組成物 |
| US20090143714A1 (en) | 2007-11-29 | 2009-06-04 | Cheri Lynn Millikin | Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives |
| KR101480700B1 (ko) | 2007-11-30 | 2015-01-12 | (주)아모레퍼시픽 | 복방 생약 추출물을 유효성분으로 함유하는 피부 외용제조성물 |
| JP2009143860A (ja) | 2007-12-14 | 2009-07-02 | Showa Denko Kk | 養毛化粧料 |
| GB0724550D0 (en) | 2007-12-18 | 2008-01-30 | Univ Hull | Formulations |
| JP2011507867A (ja) | 2007-12-19 | 2011-03-10 | イーエルシー マネージメント エルエルシー | トラメテス属の抽出物を用いた皮膚処置用組成物および方法 |
| US9717658B2 (en) | 2007-12-20 | 2017-08-01 | L'oreal | O/W emulsions containing a hydrophobic modified inulin and at least one thickening polysaccharide of plant origin |
| GB0800149D0 (en) | 2008-01-04 | 2008-02-13 | Novolytics Ltd | Improved host range phage |
| WO2009086614A1 (en) | 2008-01-08 | 2009-07-16 | Albert Knab | Method and application of synbiotic food/feed composition for humans and animals |
| ES2324192B1 (es) | 2008-01-30 | 2010-06-17 | PUIG BEAUTY & FASHION GROUP, S.L. | Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas. |
| US20090305387A1 (en) * | 2008-01-30 | 2009-12-10 | Ganeden Biotech, Inc. | Compositions and methods for cleaning surfaces |
| FR2927254B1 (fr) | 2008-02-12 | 2010-03-26 | Lesaffre & Cie | Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques |
| US20120003178A1 (en) | 2008-02-19 | 2012-01-05 | Novogen Research Pty Ltd | Evaluating the therapeutic potential of a glucan |
| JP2009242309A (ja) | 2008-03-31 | 2009-10-22 | Ezaki Glico Co Ltd | 皮膚外用剤、口腔用組成物および飲食品 |
| FR2929509B1 (fr) | 2008-04-02 | 2011-01-21 | Lvmh Rech | L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle. |
| EP2265724A4 (en) | 2008-04-09 | 2013-01-23 | Solazyme Inc | Direct chemical modification of microbial biomass and microbial oils |
| WO2009127057A1 (en) | 2008-04-15 | 2009-10-22 | Innovactiv Inc. | Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof |
| FR2930155B1 (fr) | 2008-04-21 | 2012-08-24 | Oreal | Utilisation d'un extrait de baie, et plus particulierement de wolfberry, a titre d'agent anti-pollution |
| FR2930153B1 (fr) | 2008-04-21 | 2012-05-04 | Oreal | Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques |
| FR2930154B1 (fr) | 2008-04-21 | 2012-04-20 | Oreal | Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau |
| FR2930443B1 (fr) | 2008-04-29 | 2010-06-25 | Oreal | Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12 |
| DE102009022593A1 (de) | 2008-06-13 | 2009-12-17 | KLüBER LUBRICATION MüNCHEN KG | Schmierstoffzusammensetzung auf der Basis natürlicher und nachwachsender Rohstoffe |
| WO2009157073A1 (ja) | 2008-06-26 | 2009-12-30 | 信和薬品株式会社 | ナノ型乳酸菌 |
| JP5254682B2 (ja) | 2008-06-27 | 2013-08-07 | 株式会社ヤクルト本社 | 経口摂取用皮膚性状改善剤 |
| WO2010010345A2 (en) | 2008-07-22 | 2010-01-28 | Polybiotech Limited | Sanitising compositions and methods |
| US7842725B2 (en) | 2008-07-24 | 2010-11-30 | Ecolab USA, Inc. | Foaming alcohol compositions with selected dimethicone surfactants |
| US9376659B2 (en) | 2008-07-24 | 2016-06-28 | Arch Personal Care Products, L.P. | Personal care composition containing yeast/polyphenol ferment extract |
| WO2010013182A1 (en) | 2008-07-29 | 2010-02-04 | L'oreal | Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| FR2938437B1 (fr) | 2008-11-19 | 2020-03-27 | Société des Produits Nestlé S.A. | Utilisation cosmetique de microorganisme pour le traitement des peaux grasses |
| DE102008038479A1 (de) | 2008-08-20 | 2010-02-25 | Henkel Ag & Co. Kgaa | Wasch- oder Reinigungsmittel mit gesteigerter Waschkraft |
| PL2315782T3 (pl) | 2008-08-20 | 2017-06-30 | Cargill, Incorporated | Nowy materiał polidekstrozowy |
| US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| WO2010042991A1 (en) | 2008-10-15 | 2010-04-22 | Novogen Research Pty Ltd | Methods of treatment utilising glucan formulations |
| FR2937547B1 (fr) | 2008-10-28 | 2012-11-09 | Oreal | Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses |
| FR2937536B1 (fr) | 2008-10-28 | 2016-07-01 | Oreal | Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras |
| RU2474413C1 (ru) | 2008-11-07 | 2013-02-10 | Колгейт-Палмолив Компани | Очищающие композиции |
| US11147722B2 (en) | 2008-11-10 | 2021-10-19 | Kimberly-Clark Worldwide, Inc. | Absorbent article with a multifunctional acrylate skin-adhesive composition |
| EP2346477A4 (en) | 2008-11-11 | 2015-04-08 | Colgate Palmolive Co | COMPOSITION WITH A COLOR AS AN ADVICE ON COVER |
| JP2012508031A (ja) | 2008-11-11 | 2012-04-05 | ダニスコ・ユーエス・インク | 1以上の組み合わせ変異を含むプロテアーゼ |
| BRPI0823277A2 (pt) | 2008-11-11 | 2015-06-23 | Colgate Palmolive Co | Composição, e , método |
| JP2010150240A (ja) | 2008-11-20 | 2010-07-08 | Oppen Keshohin Kk | ニゲロオリゴ糖を有効成分とする皮膚外用剤、抗炎症剤、美白剤および化粧料 |
| FR2938768B1 (fr) | 2008-11-21 | 2011-02-11 | Limousine D Applic Biolog Ditesilab Soc Ind | Utilisation cosmetique d'un extrait de pichia pour restructurer la peau, principe actif, procede d'obtention et compositions |
| US7902134B1 (en) | 2008-11-24 | 2011-03-08 | The Clorox Company | Natural personal cleanser compositions |
| WO2010061383A1 (en) | 2008-11-26 | 2010-06-03 | Biodalia Microbiological Technologies Ltd. | A method of in-situ enrichment of foods with fructan |
| JP2010126484A (ja) | 2008-11-27 | 2010-06-10 | Bioskintech Inc | 抗菌剤組成物 |
| JP2010132629A (ja) | 2008-12-03 | 2010-06-17 | Triple Act:Kk | 皮膚外用組成物 |
| GB2466195A (en) | 2008-12-10 | 2010-06-16 | Sharad Mohan | Microbiotic Soap containing yoghurt bacteria |
| US8623336B2 (en) | 2008-12-15 | 2014-01-07 | Council Of Scientific & Industrial Research | Transparent xyloglucan/chitosan gel and a process for the preparation thereof |
| DE102008064481A1 (de) | 2008-12-18 | 2010-08-12 | Bode Chemie Gmbh | Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit |
| EP2378874A2 (en) | 2008-12-18 | 2011-10-26 | Minntech Corporation | Sporicidal hand sanitizing lotion |
| FR2940098B1 (fr) | 2008-12-19 | 2011-02-18 | Oreal | Composition cosmetique fluide sous forme d'emulsion eau-dans-huile |
| JP5791009B2 (ja) | 2008-12-22 | 2015-10-07 | アサヒグループホールディングス株式会社 | 乳酸菌およびそれらを用いた飲食物又は化粧品 |
| JP2012100535A (ja) | 2009-01-28 | 2012-05-31 | Kaneka Corp | アスタキサンチン含有ファフィア属酵母抽出物の製造法 |
| US10022468B2 (en) | 2009-02-02 | 2018-07-17 | Kimberly-Clark Worldwide, Inc. | Absorbent articles containing a multifunctional gel |
| EP2216391A1 (en) | 2009-02-02 | 2010-08-11 | The Procter & Gamble Company | Liquid hand dishwashing detergent composition |
| CA2751171A1 (en) | 2009-02-02 | 2010-08-05 | The Procter & Gamble Company | Liquid hand dishwashing detergent composition |
| ES2461892T3 (es) | 2009-02-02 | 2014-05-21 | The Procter & Gamble Company | Composición detergente líquida para lavado de vajillas a mano |
| EP2216392B1 (en) | 2009-02-02 | 2013-11-13 | The Procter and Gamble Company | Liquid hand dishwashing detergent composition |
| EP3023483A1 (en) | 2009-02-02 | 2016-05-25 | The Procter and Gamble Company | Liquid hand diswashing detergent composition |
| US20110294731A1 (en) | 2009-02-13 | 2011-12-01 | Invitrx, Inc. | Skin cream |
| FR2942720B1 (fr) | 2009-03-03 | 2024-01-19 | Oreal | Utilisation cosmetique d'hesperidine. |
| FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
| RU2011135505A (ru) | 2009-03-06 | 2013-04-20 | Федерасьон Де Продюктер Асериколь Дю Кебек | Симбиотические композиции продукта из клена и способы |
| US20100233128A1 (en) | 2009-03-13 | 2010-09-16 | Mci Media Capital Inc. | Natural Skin Products Containing Dairy and Processes |
| US8178106B2 (en) | 2009-03-30 | 2012-05-15 | Mary Kay Inc. | Topical skin care formulations |
| US8084409B2 (en) | 2009-04-21 | 2011-12-27 | Bella Bella, Inc. | Microdermabrasion soap bar compositions and methods of preparing same |
| WO2010124280A2 (en) | 2009-04-24 | 2010-10-28 | New Century Pharmaceuticals, Inc. | Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions |
| WO2010126414A1 (en) | 2009-04-29 | 2010-11-04 | Sca Hygiene Products Ab | A method for retaining the activity of probiotic bacteria in personal care articles and a personal care article comprising the probiotic bacteria |
| WO2010128906A1 (en) | 2009-05-06 | 2010-11-11 | Sca Hygiene Products Ab | Sanitary article with probiotic effect |
| EP2248907A1 (en) | 2009-05-08 | 2010-11-10 | Rijksuniversiteit Groningen | Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them |
| EP2251022A1 (en) | 2009-05-11 | 2010-11-17 | Nestec S.A. | Non-replicating micro-organisms and their immune boosting effect |
| DE102009003026A1 (de) | 2009-05-12 | 2010-11-18 | Henkel Ag & Co. Kgaa | Probiotisches Handgeschirrspülmittel |
| DE102009003027A1 (de) | 2009-05-12 | 2010-12-02 | Henkel Ag & Co. Kgaa | Probiotischer Reiniger für harte Oberflächen |
| AU2010202421B2 (en) | 2009-06-15 | 2014-05-08 | Gojo Industries, Inc. | Method and compositions for use with gel dispensers |
| FR2946880B1 (fr) | 2009-06-22 | 2011-07-15 | Oreal | Composition contenant un extrait de bacterie filamenteuse et procede de traitement cosmetique des signes du vieillissement |
| WO2011003062A2 (en) | 2009-07-03 | 2011-01-06 | James Madison University | Probiotic compositions and processes thereof |
| WO2011019668A1 (en) | 2009-08-09 | 2011-02-17 | Meltology, Llc | Topical cosmeceutical formulation and methods of making and using same |
| US20120276612A1 (en) | 2009-08-12 | 2012-11-01 | Tzu Chi Buddhist General Hospital | Phage of acinetobacter baumannii |
| GB2472790A (en) | 2009-08-18 | 2011-02-23 | Laurence Christian Hayes | Dermatological preparations comprising microbes. |
| FR2949684B1 (fr) | 2009-09-04 | 2011-12-16 | Silab Sa | Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau |
| IT1398730B1 (it) | 2009-09-08 | 2013-03-18 | Giuliani Spa | Ceppo batterico probiotico e suoi usi per via orale e topica |
| FR2949970B1 (fr) | 2009-09-15 | 2011-09-02 | Oreal | Utilisation d'une huile siccative pour proteger la couleur vis-a-vis du lavage de fibres keratiniques teintes artificiellement ; procedes de coloration |
| WO2011035158A2 (en) | 2009-09-17 | 2011-03-24 | Guthery B Eugene | Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| GB2474041A (en) | 2009-10-02 | 2011-04-06 | Omorovicza Cosmetics Ltd | Cosmetic composition comprising thermal mineral water |
| EP2316465A1 (en) | 2009-10-15 | 2011-05-04 | Centre National De La Recherche Scientifique | Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons |
| FR2951377B1 (fr) | 2009-10-21 | 2012-06-22 | Oreal | Association d'un lysat de probiotique et d'un derive c-glycoside |
| KR101826531B1 (ko) | 2009-10-30 | 2018-02-07 | 바이오제닉 이노베이션스 엘엘씨 | 약물 저항성 미생물 치료를 위한 메틸설포닐메탄 |
| CZ2009724A3 (cs) | 2009-11-04 | 2011-02-09 | Bio Agens Research And Development - Bard, S.R.O. | Protiplísnová smes s houbovým organismem Pythium oligandrum |
| WO2011061144A2 (en) | 2009-11-20 | 2011-05-26 | Basf Se | The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen |
| GB0920846D0 (en) | 2009-11-27 | 2010-01-13 | Croda Int Plc | Defenin inducing agent |
| KR101640857B1 (ko) | 2009-11-30 | 2016-08-01 | (주)아모레퍼시픽 | 피부 개선용 유중수형 메이크업 화장료 조성물 |
| FR2953407B1 (fr) | 2009-12-08 | 2013-06-14 | Oreal | Microorganismes probiotiques a titre d'actif contre les alterations du microrelief |
| FR2953408B1 (fr) | 2009-12-08 | 2013-02-08 | Oreal | Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau |
| WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
| ES2364012B1 (es) | 2009-12-11 | 2012-07-12 | José Antonio Novejarque Conde | Formulación base para productos cosméticos. |
| FR2954140A1 (fr) | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
| CN102651973A (zh) | 2009-12-18 | 2012-08-29 | 希尔氏宠物营养品公司 | 包含益生菌的宠物食物组合物及其制造和使用方法 |
| JP2011168520A (ja) | 2010-02-17 | 2011-09-01 | Kikumasamune Shuzo Kk | メラニン生成抑制効果を有する乳酸菌およびその用途 |
| FR2956322A1 (fr) | 2010-02-17 | 2011-08-19 | Urgo Lab | Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie. |
| PL219328B1 (pl) | 2010-02-25 | 2015-04-30 | Global Cosmed Spółka Akcyjna | Preparat kosmetyczny do mycia i pielęgnacji ciała |
| FR2956818B1 (fr) | 2010-02-26 | 2012-07-20 | Isp Investments Inc | Utilisation d'un hydrolysat peptidique de lin dans une composition pour apaiser la peau |
| FR2957081B1 (fr) | 2010-03-02 | 2012-06-08 | Oreal | Composes de type ester de dibenzylidene sorbitol, procede de preparation, utilisation, compositions les comprenant et procede de traitement cosmetique |
| CN107794230B (zh) | 2010-03-11 | 2021-10-12 | 帝斯曼知识产权资产管理有限公司 | 酵母菌株及其在脂类产生中的用途 |
| EP2364712B1 (en) | 2010-03-11 | 2013-03-06 | Kloarys Investment Ltd | Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same |
| US8465731B2 (en) | 2010-03-12 | 2013-06-18 | Elc Management, Llc | Probiotic color cosmetic compositions and methods |
| JP2011195601A (ja) | 2010-03-17 | 2011-10-06 | Dsp Gokyo Food & Chemical Co Ltd | 低分子化ガラクトキシログルカン及びそれを含有する乳化組成物 |
| US20160074460A1 (en) | 2010-03-23 | 2016-03-17 | Namita Deo | Plant extractions, compositions containing same, and uses thereof |
| JP2011195537A (ja) | 2010-03-23 | 2011-10-06 | Noevir Co Ltd | 抗酸化剤、美白剤、抗老化剤、育毛剤、保湿剤、皮膚外用剤及び機能性経口組成物 |
| EP2549993A4 (en) | 2010-03-23 | 2014-08-06 | Gojo Ind Inc | ANTIMICROBIAL COMPOSITIONS |
| ES2384060B1 (es) | 2010-03-24 | 2013-09-23 | Lipotec S.A. | Cápsulas de nanopartículas lipídicas. |
| FR2957923B1 (fr) | 2010-03-25 | 2013-06-28 | Greentech | Nouvel extrait d'halymenia durvillei, procede pour preparer un tel extrait et son utilisation cosmetique |
| US9301982B2 (en) | 2010-04-14 | 2016-04-05 | Ganeden Biotech, Inc. | Probiotic confection and lipid compositions |
| WO2011130788A1 (en) | 2010-04-20 | 2011-10-27 | Fit-Bioceuticals Pty Ltd | Combined method for improving the health of skin |
| FR2959126B1 (fr) | 2010-04-22 | 2012-07-06 | Silab Sa | Utilisation cosmetique d'oligoglucomannanes d'amorphophallus konjac |
| FR2959128B1 (fr) | 2010-04-23 | 2012-07-13 | Oreal | Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles |
| US9814737B2 (en) | 2010-04-27 | 2017-11-14 | Mercy Medical Research Institute | Composition for skin sanitization and protection and method of its use |
| KR100999429B1 (ko) | 2010-04-28 | 2010-12-09 | (주)네오크레마 | 비만 치료 및 항산화 활성을 갖는 효모 가수분해물 |
| US20110280850A1 (en) | 2010-05-12 | 2011-11-17 | Starr Elizabeth I | Compositions Containing DNA Repair Enzyme And Anogeissus Extract |
| HUE026862T2 (en) | 2010-05-24 | 2016-07-28 | Indena Spa | Combined vegetable extracts for use in the treatment of microbiological infections |
| FR2961402B1 (fr) | 2010-06-17 | 2014-01-31 | Soliance | Compositions contenant des arabinoxylo-oligosaccharides et leurs utilisations |
| EP2397145A1 (en) | 2010-06-18 | 2011-12-21 | Nestec S.A. | L. johnsonii La1, B. longum NCC2705 and immune disorders |
| GB201010256D0 (en) | 2010-06-18 | 2010-07-21 | Reckitt Benckiser Inc | Germicidal topical compositions |
| JP2013530995A (ja) | 2010-06-30 | 2013-08-01 | ネステク ソシエテ アノニム | 皮膚の色素沈着を調節するための、栄養補助食品におけるチコリ酸及び誘導体の使用 |
| SG186804A1 (en) | 2010-06-30 | 2013-02-28 | Nestec Sa | Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation |
| KR101850165B1 (ko) | 2010-06-30 | 2018-04-18 | 네스텍 소시에테아노님 | 피부 색소침착 조절용 식품 보충제에 있어서 카프타르산 및 락틱 박테리아의 용도 |
| EP2412792A1 (en) | 2010-07-29 | 2012-02-01 | The Procter & Gamble Company | Liquid detergent composition |
| WO2012013776A2 (en) | 2010-07-30 | 2012-02-02 | Nestec S.A. | Use of green coffee beans for regulating skin pigmentation disorders |
| JP2013535461A (ja) | 2010-07-30 | 2013-09-12 | ネステク ソシエテ アノニム | 皮膚色素沈着を調節するための焙煎コーヒー豆の使用 |
| FR2963560A3 (fr) | 2010-08-03 | 2012-02-10 | Sephar Soc D Etudes Pharma | Nouvelle composition pharmaceutique et cosmetique et ses applications dans le traitement des epidermes deshydrates et dans le traitement et la prevention des reactions cutanees inflammatoires |
| EP2420580A1 (en) | 2010-08-18 | 2012-02-22 | AB-Biotics, S.A. | Probiotic composition for oral health |
| BR112013003895A2 (pt) | 2010-08-19 | 2016-07-12 | Merz Pharma Gmbh & Co Kgaa | composição de enchimento e seu uso, processo para a preparação da composição de enchimento, kit e dispositivo de injeção |
| JP5274525B2 (ja) | 2010-09-03 | 2013-08-28 | 株式会社東洋発酵 | 美白組成物、及びこれらを含有する化粧品 |
| WO2012033854A2 (en) | 2010-09-07 | 2012-03-15 | Grid Net, Inc. | Power outage notification |
| US20120128755A1 (en) | 2010-09-30 | 2012-05-24 | James Vincent Gruber | Personal Care Composition Containing Yeast Extract And Hexapeptide |
| US20120237494A1 (en) | 2010-09-30 | 2012-09-20 | Daly Susan M | Compositions Containing Zinc PCA And Anogeissus Extract |
| GB2484134B (en) | 2010-10-01 | 2013-01-30 | Cleveland Biotech Ltd | Cleaning compositions |
| US20120082657A1 (en) | 2010-10-04 | 2012-04-05 | Yim Ji Soo | Skin preparation containing fermented soybean paste |
| IT1405781B1 (it) | 2010-10-12 | 2014-01-24 | Antropoli | Uso di un preparato basato su micro-patch di caffeina e polisaccaridi di betaglucano in trattamenti antirughe. |
| ES2583004T3 (es) | 2010-10-13 | 2016-09-16 | Vigenent Inc. | Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina |
| CA2815259A1 (en) | 2010-10-27 | 2012-05-03 | Quantibact A/S | Capture of target dna and rna by probes comprising intercalator molecules |
| US20120108488A1 (en) | 2010-10-29 | 2012-05-03 | Neil Joseph Lant | Cleaning And/Or Treatment Compositions |
| US20120114776A1 (en) | 2010-11-04 | 2012-05-10 | Janos Feher | Methods for preparing probiotic nanoparticles |
| EP2452576A1 (en) | 2010-11-11 | 2012-05-16 | Nestec S.A. | Extruded non-replicating probiotic micro-organisms and their health benefits |
| CN102000009B (zh) | 2010-11-12 | 2012-06-06 | 中国农业科学院油料作物研究所 | 一种含亚麻籽油的洗面膏及其制备方法 |
| KR20190086482A (ko) | 2010-11-12 | 2019-07-22 | 알러간, 인코포레이티드 | 물질대사된 조건화 성장 배지 및 이용 방법 |
| KR101346661B1 (ko) | 2010-11-15 | 2014-02-06 | 부경대학교 산학협력단 | 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물 |
| EP2465507A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
| US20130302298A1 (en) | 2010-11-30 | 2013-11-14 | Bio-K Plus International Inc. | Treatment and prevention of eczema |
| FR2968211B1 (fr) | 2010-12-02 | 2013-07-12 | Oreal | Utilisation d'extrait de levure du genre saccharomyces pour ameliorer l'eclat du teint et composition comprenant au moins cet extrait et un agent depigmentant |
| WO2012077120A2 (en) | 2010-12-09 | 2012-06-14 | Y&B Mother's Choice Ltd. | Natural formulations |
| US20150125498A1 (en) | 2010-12-15 | 2015-05-07 | Speximo Ab | New particle stabilized emulsions and foams |
| FR2968990B1 (fr) | 2010-12-17 | 2013-02-22 | Oreal | " utilisation de population microbienne stable comme agent pour stimuler la regeneration epidermique de la peau suite a un traitement cosmetique de nature chimique et/ou mecanique et/ou physique" |
| FR2968951B1 (fr) | 2010-12-20 | 2012-12-28 | Oreal | Composition cosmetique comprenant un compose d'acide cucurbique |
| KR101947126B1 (ko) | 2010-12-28 | 2019-02-13 | 카메디스 리미티드 | 감염의 치료 및 예방을 위한 식물 추출물 |
| KR101902035B1 (ko) | 2011-01-25 | 2018-09-27 | 오스트리아노바 싱가포르 피티이 리미티드 | 산성 분해로부터 미생물 세포의 보호 |
| DE102011009798B4 (de) | 2011-01-31 | 2015-03-05 | Merz Pharma Gmbh & Co. Kgaa | Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen |
| ES2629910T3 (es) | 2011-02-11 | 2017-08-16 | Laboratorios Cinfa, S.A. | Principio activo obtenido biotecnológicamente en composiciones cosméticas útiles para proteger la piel de daños inducidos o producidos por radiaciones infrarrojas |
| CN103687604A (zh) | 2011-03-01 | 2014-03-26 | 群体创新有限责任公司 | 用于治疗与致病生物膜相关之病症的材料和方法 |
| EP2694030A2 (en) | 2011-03-04 | 2014-02-12 | Sana Pharma AS | Cosmetic formulations |
| KR101811912B1 (ko) | 2011-03-04 | 2017-12-22 | 아메드 에이치. 알-칸타니 | 스킨 크림 |
| WO2012127001A1 (en) | 2011-03-23 | 2012-09-27 | Novozymes A/S | Methods for producing secreted polypeptides |
| WO2012129683A1 (en) | 2011-03-25 | 2012-10-04 | Biopharmacopae Design International Inc. | Extracts from plants of the tsuga genus and uses thereof in the treatment of skin disorders |
| FR2973381B1 (fr) | 2011-03-28 | 2014-06-13 | Greentech | Nouveaux composes oligosaccharides et leur utilisation cosmetique |
| WO2012135499A1 (en) | 2011-03-31 | 2012-10-04 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
| US8753654B2 (en) | 2011-04-08 | 2014-06-17 | Dipak Narula | Substantially anhydrous compositions for personal care |
| EP2701679A4 (en) | 2011-04-29 | 2014-12-31 | Photomedex Inc | TOPICAL COMPOSITIONS FOR DNA REPAIR |
| DK2704704T3 (en) | 2011-05-03 | 2019-01-14 | Dupont Nutrition Biosci Aps | PROBIOTIC BACTERIES FOR TOPICAL TREATMENT OF SKIN DISORDERS |
| US9585922B2 (en) | 2011-05-06 | 2017-03-07 | Organobalance Medical Ag | Lactic acid bacteria that co-aggregate with pathogenic bacteria |
| ES2393480B1 (es) | 2011-05-09 | 2013-11-04 | Jorge CUNÍ BRAVO | Composición aglutinante para pinturas. |
| US9233062B2 (en) | 2011-05-10 | 2016-01-12 | Mary Kay Inc. | Cosmetic compositions |
| RU2651466C2 (ru) | 2011-05-16 | 2018-04-19 | ОРГАНОБАЛАНС Медикал АГ | Новые молочнокислые бактерии и содержащие их составы против бактериальных простудных заболеваний |
| FR2975295B1 (fr) | 2011-05-20 | 2014-12-26 | Oreal | Composition cosmetique comprenant un polymere superabsorbant et un glucide choisi parmi les oses, les oligosides et les homopolyholosides |
| KR20130000007A (ko) | 2011-06-14 | 2013-01-02 | 부경대학교 산학협력단 | 3-5 kDa분자량 범위를 갖는 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물 |
| EP2540170A1 (de) | 2011-06-29 | 2013-01-02 | Evonik Degussa GmbH | Dermatologisch wirksamer Hefeextrakt |
| DE102011080715A1 (de) | 2011-08-10 | 2013-02-14 | Henkel Ag & Co. Kgaa | Hautbarrierestärkendes Reinigungsmittel |
| EP2744478A4 (en) | 2011-08-17 | 2015-07-29 | Basf Corp | ACTIVE COSMETIC PRINCIPLES OF MARINE ORIGIN AND THEIR USE |
| AU2012302146A1 (en) | 2011-09-02 | 2014-04-03 | Burt's Farm, LLC | Personal care compositions comprising squash or pumpkin extract |
| CN103814033B (zh) | 2011-09-19 | 2016-07-13 | 巴斯夫欧洲公司 | 异山梨醇衍生物用于制备化妆品制剂的用途 |
| FR2980707B1 (fr) | 2011-10-03 | 2013-11-01 | Silab Sa | Utilisation de glucanes obtenus a partir de prunus persica comme agent cosmetique anti-age |
| WO2013067185A1 (en) | 2011-11-02 | 2013-05-10 | Bios Llc | Probiotic stick formulation for skin maintenance and methods of use |
| US20130230609A1 (en) | 2012-03-05 | 2013-09-05 | Shanta Modak | Antimicrobial/preservative compositions comprising botanicals |
| US9968101B2 (en) | 2011-11-03 | 2018-05-15 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
| US20130115317A1 (en) | 2011-11-08 | 2013-05-09 | The Procter & Gamble Company | Method for Identifying Pre-Biotics and Compositions Containing the Same |
| US8815538B2 (en) | 2011-11-08 | 2014-08-26 | The Procter & Gamble Company | Method of making cosmetic compositions containing a prebiotic |
| FR2982151B1 (fr) | 2011-11-09 | 2014-01-24 | Oreal | Acide gras mono-insature pour le soin des ongles |
| FR2982487B1 (fr) | 2011-11-14 | 2015-06-26 | Oreal | Utilisation d'une association de trois principes actifs pour la reconstruction du tissu adipeux et la lutte contre les signes du vieillissement cutane |
| KR101406808B1 (ko) | 2011-11-18 | 2014-06-12 | 가부시키가이샤 바이오제노믹스 | 미용 방법, 스킨케어용 조성물 및 건조 균체 |
| DE102011119033A1 (de) | 2011-11-22 | 2012-09-06 | Clariant International Ltd. | Verwendung von Isosorbidcaprylaten/capraten in Deodorantien und Antiperspirantien |
| EP2790654A2 (en) | 2011-12-12 | 2014-10-22 | Italmatch Chemicals S.P.A. | Cosmetic composition for skin or hair care |
| AU2011383312B2 (en) | 2011-12-15 | 2014-07-31 | Colgate-Palmolive Company | Cleansing compositions with polyurethane-34 |
| TWI574954B (zh) | 2011-12-28 | 2017-03-21 | 三得利控股股份有限公司 | 寡聚原花青素之製造方法、聚合度之調整方法以及透明質酸酶抑制劑與膠原酶抑制劑 |
| TW201350071A (zh) | 2012-01-06 | 2013-12-16 | Gojo Ind Inc | 液體分配器泵 |
| US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
| DE102012002592A1 (de) | 2012-02-13 | 2013-08-14 | Dr. Kurt Wolff Gmbh & Co. Kg | Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP) |
| CA2863568A1 (en) | 2012-02-14 | 2013-08-22 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
| US20130251695A1 (en) | 2012-02-28 | 2013-09-26 | Ganeden Biotech, Inc. | Cosmetic Compositions |
| US20150044317A1 (en) | 2012-02-28 | 2015-02-12 | Ganeden Biotech, Inc. | Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof |
| US9133417B2 (en) | 2012-03-23 | 2015-09-15 | The Procter & Gamble Company | Liquid cleaning and disinfecting compositions comprising an assymetrically branched amine oxide |
| JP2015517989A (ja) | 2012-03-30 | 2015-06-25 | ゴジョ・インダストリーズ・インコーポレイテッド | カチオン性の抗菌性ハンドウォッシュ |
| WO2013149323A1 (en) | 2012-04-02 | 2013-10-10 | Ntegrity | Natural products for skin care |
| GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| GB201208842D0 (en) | 2012-05-18 | 2012-07-04 | Edmire Bvba | Disposable wipe product for cleansing surfaces |
| US9101250B2 (en) | 2012-05-21 | 2015-08-11 | Gojo Industries, Inc. | Wipes dispenser nozzle |
| ITFI20120104A1 (it) | 2012-06-04 | 2013-12-05 | Damor Farmaceutici | Frazione saccaridica da grano, processo per l'isolamento ed uso. |
| US20140004214A1 (en) | 2012-06-15 | 2014-01-02 | Wisconsin Alumni Research Foundation | Methods to isolate anti-microbials from fruit or seed extracts |
| WO2013188626A2 (en) | 2012-06-15 | 2013-12-19 | Dow Global Technologies Llc | Probiotic-containing particles having improved probiotic stability when in aqueous formulations |
| WO2013190542A2 (en) | 2012-06-17 | 2013-12-27 | Kamedis Ltd | Topical compositions for the treatment of chronic inflammatory skin disease |
| MX2015000312A (es) | 2012-07-12 | 2015-04-10 | Novozymes As | Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican. |
| US20140065210A1 (en) | 2012-08-29 | 2014-03-06 | David W. Koenig | Protein stabilized probiotics and personal care products |
| IN2015DN03069A (enExample) | 2012-09-14 | 2015-10-02 | Miracle Fruit Oil L L C | |
| FR2995784B1 (fr) | 2012-09-21 | 2016-09-09 | Oreal | Composition cosmetique sous forme d'emulsion et procede de traitement cosmetique |
| CN104661644B (zh) | 2012-09-24 | 2018-11-13 | 味之素株式会社 | 含有甾醇酯的液体洗涤剂 |
| US9027790B2 (en) | 2012-10-19 | 2015-05-12 | Gojo Industries, Inc. | Dispensers for diluting a concentrated liquid and dispensing the diluted concentrate |
| FR2997304B1 (fr) | 2012-10-26 | 2017-07-07 | Isp Investments Inc | Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens |
| AU2013360086A1 (en) | 2012-12-13 | 2015-07-02 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
| FR2999429B1 (fr) | 2012-12-18 | 2015-01-02 | Expanscience Lab | Extrait de graines de passiflore et compositions cosmetiques, pharmaceutiques, dermatologiques ou nutraceutiques le comprenant |
| WO2014107572A1 (en) | 2013-01-04 | 2014-07-10 | ARMS Pharmaceutical LLC | Body surface treatment composition and method |
| US8827119B2 (en) | 2013-01-23 | 2014-09-09 | Gojo Industries, Inc. | Pull pumps, refill units and dispensers for pull pumps |
| US8740019B1 (en) | 2013-02-18 | 2014-06-03 | Gojo Industries, Inc. | Foam dispensing systems with multiple liquid supplies, and related refill units |
| US9089506B2 (en) | 2013-02-27 | 2015-07-28 | Precision Dermatology, Inc. | Stable, non-irritating topical formulations of hydroquinone |
| WO2014131191A1 (en) | 2013-03-01 | 2014-09-04 | Johnson & Johnson Consumer Companies, Inc. | A composition containing honokiol and/or magnolol and uses thereof |
| US20150320038A1 (en) | 2013-03-01 | 2015-11-12 | Garden Art Innovations, Llc | Hand Sanitizer with Soft Focus Effect on the Skin |
| CN105142600A (zh) | 2013-03-15 | 2015-12-09 | 前沿创新有限公司 | 包含高水平水混溶性溶剂之疏水剂的基本上不含表面活性剂的亚微米分散体 |
| GB2512343A (en) | 2013-03-27 | 2014-10-01 | Reckitt Benckiser Brands Ltd | Skincare compositions |
| WO2014162125A1 (en) | 2013-04-01 | 2014-10-09 | Gencoa Ltd | Bio control activity surface |
| US20140308258A1 (en) | 2013-04-12 | 2014-10-16 | Charles Joseph Matthews | Enhanced microbial strains for the prevention and treatment of methicillin-resistant staphylococcus aureus and methicillin-resistant staphylococcus epidermis infection |
| US9579278B2 (en) | 2013-05-10 | 2017-02-28 | Johnson & Johnson Consumer Inc. | Compositions comprising extracts of Bursera simaruba |
| KR20160018572A (ko) | 2013-05-20 | 2016-02-17 | 바이오위시 테크놀로지스, 인크. | 미생물에 기반한 폐수 처리 조성물 및 그 사용 방법 |
| US20140356295A1 (en) | 2013-06-03 | 2014-12-04 | R.J. Reynolds Tobacco Company | Cosmetic compositions comprising tobacco seed-derived component |
| US9439841B2 (en) | 2013-06-06 | 2016-09-13 | Ecolab Usa Inc. | Alcohol based sanitizer with improved dermal compatibility and feel |
| DK3016511T3 (da) | 2013-07-02 | 2020-01-13 | Austrianova Singapore Pte Ltd | En fremgangsmåde til at frysetørre indkapslede celler, sammensætninger egnet til at fryse indkapslede celler og anvendelse af sådanne sammensætninger |
| US20150024073A1 (en) | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing extracts of malva neglecta |
| US20150024074A1 (en) | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies Inc. | Methods for treating skin barrier and reducing acne |
| US20150024077A1 (en) | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies Inc. | Composition for treating skin barrier and reducing acne |
| US20150024072A1 (en) | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a skin condition with malva neglecta |
| AU2014324694B2 (en) | 2013-09-30 | 2017-06-29 | Elc Management Llc | Watery lotion skin care compositions and methods |
| GB201320409D0 (en) | 2013-11-19 | 2014-01-01 | Univ Aberystwyth | Prebiotic composition |
| CN103599051A (zh) | 2013-11-27 | 2014-02-26 | 潘永 | 一种洗面奶及其制作方法 |
| DE102013225844A1 (de) | 2013-12-13 | 2015-06-18 | Henkel Ag & Co. Kgaa | Kosmetische Zusammensetzung enthaltend eine Kombination aus Oligopeptiden und Ceramiden |
| ES2723948T3 (es) | 2013-12-13 | 2019-09-04 | Danisco Us Inc | Serina proteasas procedentes de especies de Bacillus |
| EP3092008A4 (en) | 2014-01-10 | 2017-09-06 | The Regents of The University of California | Skin probiotic |
| US20150209392A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Filaments Comprising a Microorganism and Method for Making Same |
| US20160338361A1 (en) | 2014-02-04 | 2016-11-24 | Micro-Nature Llc | Systems, methods, and compositions for promoting pathogen control and food preservation |
| GB2523340A (en) | 2014-02-20 | 2015-08-26 | Sheikha Fatima Al Thani | Composition |
| AU2015229610A1 (en) | 2014-03-10 | 2016-09-22 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
| US10442610B2 (en) | 2014-03-11 | 2019-10-15 | Starbucks Corporation | Pod-based restrictors and methods |
| US11135456B2 (en) | 2014-03-14 | 2021-10-05 | Gojo Industries, Inc. | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines |
| CN106170546A (zh) | 2014-03-21 | 2016-11-30 | 丹尼斯科美国公司 | 芽孢杆菌属的丝氨酸蛋白酶 |
| AU2015242227B2 (en) | 2014-03-31 | 2020-04-16 | Lubrizol Advanced Materials, Inc. | Ferment extract of a bacterial strain for the increase of adiponectin levels |
| EP2929873A1 (en) | 2014-04-07 | 2015-10-14 | Intermed S.A. | Skin cleansing compositions |
| US20150305343A1 (en) | 2014-04-28 | 2015-10-29 | American Sterilizer Company | Process and composition for killing spores |
| EP3139939B1 (en) | 2014-05-07 | 2023-09-06 | The Regents of The University of California | Compositions and methods for treating skin and mucous membrane diseases |
| CA2947436A1 (en) * | 2014-05-12 | 2015-11-19 | BiOWiSH Technologies, Inc. | Compositions and methods for improving human health and nutrition |
| EP3152290A1 (en) | 2014-06-04 | 2017-04-12 | Novozymes A/S | Detergent composition |
| DE102014211204A1 (de) | 2014-06-12 | 2015-12-17 | Henkel Ag & Co. Kgaa | Verwendung kosmetischer Reinigungszusammensetzungen als Präbiotikum |
| US20160000858A1 (en) | 2014-07-07 | 2016-01-07 | Gojo Industries, Inc. | Compositions and methods for mitigating skin irritation and enhancing skin barrier function |
| US9096821B1 (en) | 2014-07-31 | 2015-08-04 | The Clorox Company | Preloaded dual purpose cleaning and sanitizing wipe |
| HRP20230358T1 (hr) | 2014-08-06 | 2023-06-09 | Envera Lic, Llc | Pripravci bakterijskih spora za industrijske uporabe |
| CN104274357B (zh) | 2014-09-05 | 2017-07-18 | 拉芳家化股份有限公司 | 一种含有植物酊剂的头皮护理组合物及其制备方法 |
| CN104666285B (zh) | 2015-01-30 | 2017-08-22 | 天津顶硕药业股份有限公司 | 薁磺酸钠抗过敏免洗快干净手剂 |
| US9855222B2 (en) | 2015-03-27 | 2018-01-02 | The Idea Folder Llc | Topical sanitizer that includes avenanthramides |
| CN104862098A (zh) | 2015-04-15 | 2015-08-26 | 青岛康泰鑫环保科技有限公司 | 一种消毒洗涤剂 |
| US11406671B2 (en) | 2015-04-24 | 2022-08-09 | The Translational Genomics Research Institute | Compositions and methods for augmenting the nasal microbiome |
| CN104997674A (zh) | 2015-07-09 | 2015-10-28 | 广东长荣林业发展股份有限公司 | 一种润肤霜及其制备方法 |
| CN105106062A (zh) | 2015-08-26 | 2015-12-02 | 拉芳家化股份有限公司 | 一种防脱发植物精油组合物及其制备方法及应用 |
| FR3040624B1 (fr) | 2015-09-09 | 2019-07-26 | Gallinee Ltd | Compositions comprenant en association des prebiotiques, des fractions probiotiques et de l'acide lactique |
| CN105482915A (zh) | 2016-02-01 | 2016-04-13 | 东莞品派实业投资有限公司 | 一种护肤杀菌洗洁精 |
| CN105796377A (zh) | 2016-03-18 | 2016-07-27 | 西安膳方医药科技有限公司 | 一种通过微生态调整改善生物体表健康的方法 |
| CA3018987A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Topical cleansing composition with prebiotic/probiotic additive |
| EP3435765A1 (en) | 2016-03-31 | 2019-02-06 | Gojo Industries, Inc. | Antimicrobial peptide stimulating sanitizing composition |
| WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| JP2019510036A (ja) * | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物 |
| AU2017240656A1 (en) | 2016-03-31 | 2018-11-15 | Gojo Industries, Inc. | Topical composition for reducing pathogen binding |
| CA3044670A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Topical cleansing composition with prebiotic/probiotic additive |
| JP2019535766A (ja) | 2016-11-23 | 2019-12-12 | ゴジョ・インダストリーズ・インコーポレイテッド | 抗菌ペプチド刺激性洗浄組成物 |
| CA3043745A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Antimicrobial peptide stimulating sanitizing composition |
-
2017
- 2017-11-21 EP EP17817958.6A patent/EP3544575A1/en not_active Withdrawn
- 2017-11-21 US US15/819,634 patent/US11564879B2/en active Active
- 2017-11-21 AU AU2017365019A patent/AU2017365019A1/en not_active Abandoned
- 2017-11-21 WO PCT/US2017/062784 patent/WO2018098152A1/en not_active Ceased
- 2017-11-21 CA CA3043748A patent/CA3043748A1/en not_active Abandoned
- 2017-11-21 JP JP2019527882A patent/JP2020500860A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017365019A1 (en) | 2019-07-11 |
| EP3544575A1 (en) | 2019-10-02 |
| US11564879B2 (en) | 2023-01-31 |
| WO2018098152A1 (en) | 2018-05-31 |
| JP2020500860A (ja) | 2020-01-16 |
| US20180140539A1 (en) | 2018-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11998575B2 (en) | Sanitizer composition with probiotic/prebiotic active ingredient | |
| US11564879B2 (en) | Sanitizer composition with probiotic/prebiotic active ingredient | |
| US20170281660A1 (en) | Topical composition for reducing pathogen binding | |
| US20170281694A1 (en) | Topical cleansing composition with prebiotic/probiotic additive | |
| US20180140540A1 (en) | Topical cleansing composition with prebiotic/probiotic additive | |
| AU2017240064B2 (en) | Antimicrobial peptide stimulating sanitizing composition | |
| US20180140527A1 (en) | Antimicrobial peptide stimulating cleansing composition | |
| US20180140545A1 (en) | Antimicrobial peptide stimulating sanitizing composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20240304 |